{"DataElement":{"publicId":"13362278","version":"1","preferredName":"Gene Mutation Common Name","preferredDefinition":"The words by which the generally used name of the mutation is known.","longName":"13328474v1.00:13341037v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13328474","version":"1","preferredName":"Gene Mutation Common Name","preferredDefinition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.:The generally-used, literal identifier of the entity.","longName":"3226153v1.00:13328473v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"3226153","version":"1","preferredName":"Gene Mutation","preferredDefinition":"change occurring in one gene.","longName":"C18093","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A058FC46-E459-AC72-E040-BB89AD4365D6","latestVersionIndicator":"Yes","beginDate":"2011-04-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-07","modifiedBy":"ONEDATA","dateModified":"2011-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13328473","version":"1","preferredName":"Common Name","preferredDefinition":"The generally-used, literal identifier of the entity.","longName":"C164471","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Name","conceptCode":"C164471","definition":"The generally-used, literal identifier of the entity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8B08534-C628-6D25-E053-731AD00AECEF","latestVersionIndicator":"Yes","beginDate":"2023-04-06","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-06","modifiedBy":"JKNABLE","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F8B08534-C630-6D25-E053-731AD00AECEF","latestVersionIndicator":"Yes","beginDate":"2023-04-06","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-06","modifiedBy":"ZHWENDY","dateModified":"2023-04-24","changeDescription":null,"administrativeNotes":"4/24/2023: added Origin to DEC.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13341037","version":"1","preferredName":"Gene Mutation Name","preferredDefinition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA._The words or language units by which a thing is known.","longName":"13341037v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"t(15;17)(q24;q21)","valueDescription":null,"ValueMeaning":{"publicId":"5219770","version":"1","preferredName":"t(15;17)(q22;q12)","longName":"5219770","preferredDefinition":"A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of Acute Promyelocytic Leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(15;17)(q24;q21)","conceptCode":"C27758","definition":"A chromosomal translocation associated with creation of a fusion between the PML and RARA genes. It is seen in variants of acute promyelocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"305FB5C7-0ECA-4760-E050-BB89AD43474E","latestVersionIndicator":"Yes","beginDate":"2016-04-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-04-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A4-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(9;11)(p22;q23) / MLL-MLLT3(AF9)","valueDescription":null,"ValueMeaning":{"publicId":"13336613","version":"1","preferredName":"t(9;11)(p21.3;q23.3)","longName":"13336613v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p21.3) of chromosome 9 and the long arm (q23.3) of chromosome 11. It is associated with the development of acute myeloid leukemia with the MLLT3-MLL fusion gene transcript.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;11)(p21.3;q23.3)","conceptCode":"C36370","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p21.3) of chromosome 9 and the long arm (q23.3) of chromosome 11. It is associated with the development of acute myeloid leukemia with the MLLT3-MLL fusion gene transcript.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FC-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A5-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(10;11)(p12;q23) / MLL-MLLT10(AF10)","valueDescription":null,"ValueMeaning":{"publicId":"5709220","version":"1","preferredName":"t(10;11)(p12;q23)","longName":"5709220","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 10p12 with chromosome 11q23. It is associated with acute myeloid leukemia in childhood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(10;11)(p12;q23)","conceptCode":"C132102","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 10p12 with chromosome 11q23. It is associated with acute myeloid leukemia in childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A9E460A-03CD-1810-E053-F662850AD355","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-03-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A6-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(10;11)(p11.2;q23)","valueDescription":null,"ValueMeaning":{"publicId":"13336603","version":"1","preferredName":"t(10;11)(p11.2;q23)","longName":"13336603v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 10 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/ABI1 fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(10;11)(p11.2;q23)","conceptCode":"C168758","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 10 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/ABI1 fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3E-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A7-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Monosomy 7","valueDescription":null,"ValueMeaning":{"publicId":"2762295","version":"1","preferredName":"Monosomy 7","longName":"2762295","preferredDefinition":"A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monosomy 7","conceptCode":"C36411","definition":"A chromosomal abnormality consisting of the absence of one of the copies of chromosome 7 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-0189-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A8-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Trisomy 8","valueDescription":null,"ValueMeaning":{"publicId":"3554906","version":"1","preferredName":"Trisomy Chromosome 8","longName":"3554906","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 8","conceptCode":"C36396","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 8 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C740F5C7-76FE-BDA9-E040-BB89AD434D2D","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00A9-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(1;11)(q21;q23) / MLL-MLLT11(AF1Q)","valueDescription":null,"ValueMeaning":{"publicId":"13336601","version":"1","preferredName":"t(1;11)(q21;q23)","longName":"13336601v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q21) of chromosome 1 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/MLLT11 (AF1Q) fusions, acute myeloid leukemia and some cases of acute lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;11)(q21;q23)","conceptCode":"C168759","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q21) of chromosome 1 and the long arm (q23) of chromosome 11. It is associated with KMT2A (MLL)/MLLT11 (AF1Q) fusions, acute myeloid leukemia and some cases of acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3C-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AA-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(6;11)(q27;q23) / MLL-MLLT4(AF6)","valueDescription":null,"ValueMeaning":{"publicId":"5709221","version":"1","preferredName":"t(6;11)(q27;q23)","longName":"5709221","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q27) of chromosome 6 and the long arm (q23) of chromosome 11. It is associated with the development of de novo acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;11)(q27;q23)","conceptCode":"C36610","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q27) of chromosome 6 and the long arm (q23) of chromosome 11. It is associated with the development of de novo acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A9E460A-03F2-1810-E053-F662850AD355","latestVersionIndicator":"Yes","beginDate":"2017-03-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-03-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AB-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13) (MLL-ENL)/(MLL-ELL)","valueDescription":null,"ValueMeaning":{"publicId":"13336607","version":"1","preferredName":"t(11;19)(q23;p13)","longName":"13336607v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT1 (ENL) and ELL, and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23;p13)","conceptCode":"C168764","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT1 (ENL) and ELL, and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F6-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AC-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13.1) (MLL-ELL)","valueDescription":null,"ValueMeaning":{"publicId":"13336606","version":"1","preferredName":"t(11;19)(q23;p13.1)","longName":"13336606v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the short arm (p13.1) of chromosome 19. It is associated with the development of acute myeloid leukemia with variant MLL translocations and topoisomerase II inhibitor-related acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23.3;p13.1)","conceptCode":"C36371","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.1) of chromosome 19. It is associated with the development of acute myeloid leukemia with variant MLL translocations and topoisomerase II inhibitor-related acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F5-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AD-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"ETV6-RUNX1 t(12;21)(p13;q22)(formerly TEL-AML1)","valueDescription":null,"ValueMeaning":{"publicId":"7307959","version":"1","preferredName":"t(12;21)(p13.2;q22.1)","longName":"7307959","preferredDefinition":"A translocation between chromosomes 12 and 21 involved in TEL-AML1 oncogene formation. The translocation produces a chimeric gene encoding a protein consisting of the N-terminal HLH domain of the TEL ETS-like transcription factor fused with a nearly complete AML1 protein. t(12;21) is the most frequent translocation causing ALL, accounting for 20% of ALL cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;21)(p13.2;q22.1)","conceptCode":"C13727","definition":"A translocation between chromosomes 12 and 21 involved in TEL-AML1 oncogene formation. The translocation produces a chimeric gene encoding a protein consisting of the N-terminal HLH domain of the TEL ETS-like transcription factor fused with a nearly complete AML1 protein. t(12;21) is the most frequent translocation causing ALL, accounting for 20% of ALL cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A53F76-D0F6-1EE7-E053-4EBD850A657D","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AE-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(8;14)(q24;q32) or other variant of B-ALL","valueDescription":null,"ValueMeaning":{"publicId":"4661105","version":"1","preferredName":"t(8;14)(q24;q32)","longName":"4661105","preferredDefinition":"A chromosomal translocation that fuses 8q24 with 14q32. This juxtaposes the MYC gene with the promoter regions of the immunoglobulin heavy chain gene locus, which results in overexpression of Myc proto-oncogene protein in B-cells bearing the translocation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(8;14)(q24;q32)","conceptCode":"C36319","definition":"A chromosomal translocation that fuses 8q24 with 14q32. This juxtaposes the MYC gene with the promoter regions of the immunoglobulin heavy chain gene locus, which results in overexpression of Myc proto-oncogene protein in B-cells bearing the translocation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C3D2DA1-60AE-3D69-E050-BB89AD432FB6","latestVersionIndicator":"Yes","beginDate":"2015-01-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-01-09","modifiedBy":"MAESKEB","dateModified":"2019-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00AF-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Trisomy 10","valueDescription":null,"ValueMeaning":{"publicId":"4535606","version":"1","preferredName":"Trisomy 10","longName":"4535606","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 10","conceptCode":"C81729","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 10 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-3342-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B0-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Trisomy 17","valueDescription":null,"ValueMeaning":{"publicId":"2762292","version":"1","preferredName":"Trisomy 17","longName":"2762292","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 17 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 17","conceptCode":"C37865","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 17 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-0114-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B1-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Trisomy 4","valueDescription":null,"ValueMeaning":{"publicId":"2762294","version":"1","preferredName":"Trisomy 4","longName":"2762294","preferredDefinition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 4 in somatic cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trisomy 4","conceptCode":"C36530","definition":"A chromosomal abnormality consisting of the presence of a third copy of chromosome 4 in somatic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510ADE83-0162-56CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B2-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"E2A/PBX1 t(1;19)","valueDescription":null,"ValueMeaning":{"publicId":"3021232","version":"1","preferredName":"Chromosome 1 Chromosome 19 Chromosomal Translocation","longName":"3021232","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;19)","conceptCode":"C128654","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 1 and 19.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8176541B-BB70-0627-E040-BB89AD431BB8","latestVersionIndicator":"Yes","beginDate":"2010-03-10","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-03-10","modifiedBy":"KUMMEROA","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B3-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"iAMP21","valueDescription":null,"ValueMeaning":{"publicId":"5094536","version":"1","preferredName":"Intrachromosomal Amplification of Chromosome 21","longName":"5094536","preferredDefinition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrachromosomal Amplification of Chromosome 21","conceptCode":"C124874","definition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2796F431-2C90-87F5-E050-BB89AD43578E","latestVersionIndicator":"Yes","beginDate":"2015-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-23","modifiedBy":"MAESKEB","dateModified":"2021-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B4-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(4;11)(q21;q23) / MLL-MLLT2(AF4)","valueDescription":null,"ValueMeaning":{"publicId":"6333811","version":"1","preferredName":"t(4;11)(q21;q23)","longName":"6333811","preferredDefinition":"A chromosomal abnormality consisting of the translocation of 4q21 with 11q23.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(4;11)(q21;q23.3)","conceptCode":"C36365","definition":"A chromosomal abnormality consisting of the translocation of 4q21 with 11q23.3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5F13B2-C579-1BBA-E053-F662850A0842","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-06-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B5-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"inv(16)(p13q22)","valueDescription":null,"ValueMeaning":{"publicId":"4340488","version":"1","preferredName":"inv(16)(p13.1q22)","longName":"4340488","preferredDefinition":"A chromosomal inversion that involves chromosome 16. It is associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(16)(p13.1;q22)","conceptCode":"C36373","definition":"A chromosomal inversion that involves chromosome 16. It is associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADC8D24-9CFA-C9E3-E040-BB89AD4350B8","latestVersionIndicator":"Yes","beginDate":"2014-06-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-06-02","modifiedBy":"COLBERTM","dateModified":"2020-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B6-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(16;16)(p13.1;q22)","valueDescription":null,"ValueMeaning":{"publicId":"4340487","version":"1","preferredName":"t(16;16)(p13.1;q22)","longName":"4340487","preferredDefinition":"A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;16)(p13.1;q22)","conceptCode":"C27759","definition":"A chromosomal translocation that involves chromosome 16. It is often associated with the development of acute myeloid leukemia CBFB-MYH11, acute myelomonocytic leukemia with abnormal eosinophils, and granulocytic sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FADC8D24-9CD5-C9E3-E040-BB89AD4350B8","latestVersionIndicator":"Yes","beginDate":"2014-06-02","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-06-02","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9156854-00B7-7BC3-E053-731AD00A6062","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;19)(q23;p13.3) (MLL-ENL)","valueDescription":null,"ValueMeaning":{"publicId":"7292213","version":"1","preferredName":"t(11;19)(q23.3;p13.3)","longName":"7292213","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.3) of chromosome 19 and . It is associated with KMT2A (MLL)/MLLT10 fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q23.3;p13.3)","conceptCode":"C36372","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23.3) of chromosome 11 and the short arm (p13.3) of chromosome 19. It is associated with KMT2A (MLL)/MLLT1 (ENL) fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0974-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90AC-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;17)(AF17)","valueDescription":null,"ValueMeaning":{"publicId":"13336605","version":"1","preferredName":"t(11;17)(q23;q12-21)","longName":"13336605v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the long arm (q12-21) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT6 (AF17), and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;17)(q23;q12-21)","conceptCode":"C168760","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 11 and the long arm (q12-21) of chromosome 19. It is associated with KMT2A (MLL) fusions, including those with MLLT6 (AF17), and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F4-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90AD-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(8;16)MOZ/CBP","valueDescription":null,"ValueMeaning":{"publicId":"7292244","version":"1","preferredName":"t(8;16)(p11.2;p13.3)","longName":"7292244","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 8 and the short arm (p13.3) of chromosome 16. It is associated with KAT6A/CREBBP fusions and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(8;16)(p11.2;p13.3)","conceptCode":"C167194","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p11.2) of chromosome 8 and the short arm (p13.3) of chromosome 16. It is associated with KAT6A/CREBBP fusions and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58D6648-C0E3-77DB-E053-F662850A458B","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90AE-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Monosomy 5","valueDescription":null,"ValueMeaning":{"publicId":"3743421","version":"1","preferredName":"Monosomy 5","longName":"3743421","preferredDefinition":"A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monosomy 5","conceptCode":"C36523","definition":"A cytogenetic aneuploidy abnormality that refers to the presence of one chromosome 5 only. It is associated with the development of refractory anemia with excess blasts, refractory anemia with multilineage dysplasia, and refractory anemia with multilineage dysplasia and ringed sideroblasts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD4B1B6-9860-7B0B-E040-BB89AD436F3F","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90AF-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"der.12p","valueDescription":null,"ValueMeaning":{"publicId":"13336599","version":"1","preferredName":"der12p","longName":"13336599v1.00","preferredDefinition":"A cytogenetic abnormality involving the rearrangement of two or more other chromosomes with the short arm of chromosome 12 (12p).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"der12p","conceptCode":"C173542","definition":"A cytogenetic abnormality involving the rearrangement of two or more other chromosomes with the short arm of chromosome 12 (12p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3A-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B0-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(2;12)","valueDescription":null,"ValueMeaning":{"publicId":"13336609","version":"1","preferredName":"t(2;12)","longName":"13336609v1.00","preferredDefinition":"A cytogenetic abnormality that involves a translocation between chromosomes 2 and 12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;12)","conceptCode":"C173543","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 2 and 12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F8-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B1-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(5;11)(q35;p15) NSD1/NUP98","valueDescription":null,"ValueMeaning":{"publicId":"13336611","version":"1","preferredName":"t(5;11)(q35;p15)","longName":"13336611v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 5q35. It results in the formation of NUP98/NSD1 fusion gene. It is associated with the development of acute myeloid leukemia with t(5;11)(q35;p15); NUP98-NSD1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(5;11)(q35;p15)","conceptCode":"C131503","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 5q35. It results in the formation of NUP98/NSD1 fusion gene. It is associated with the development of acute myeloid leukemia with t(5;11)(q35;p15); NUP98-NSD1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FA-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B2-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(7;12)(q36;p13) HLXB9(MNX1)/ETV6(TEL)","valueDescription":null,"ValueMeaning":{"publicId":"13336612","version":"1","preferredName":"t(7;12)(q36;p13)","longName":"13336612v1.00","preferredDefinition":"A chromosomal translocation involving the ETV6 gene on chromosome 12p13 and HLXB9 gene on chromosome 7q36.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(7;12)(q36;p13)","conceptCode":"C122689","definition":"A chromosomal translocation involving the ETV6 gene on chromosome 12p13 and HLXB9 gene on chromosome 7q36.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42FB-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B3-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"inv(3)(q21;q21.2)","valueDescription":null,"ValueMeaning":{"publicId":"7292242","version":"1","preferredName":"inv(3)(q21.3;q26.2)","longName":"7292242v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a paracentric inversion involving breakpoints on the long (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(3)(q21.3;q26.2)","conceptCode":"C36407","definition":"A cytogenetic abnormality that refers to a paracentric inversion involving breakpoints on the long (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58D6648-C099-77DB-E053-F662850A458B","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B4-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(3;3)(q21;q26.2), RPN1-EVI1","valueDescription":null,"ValueMeaning":{"publicId":"7292221","version":"1","preferredName":"t(3;3)(q21.3;q26.2)","longName":"7292221","preferredDefinition":"A cytogenetic abnormality that refers to the translocation where both breakpoints are on the long arm (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;3)(q21.3;q26.2)","conceptCode":"C36406","definition":"A cytogenetic abnormality that refers to the translocation where both breakpoints are on the long arm (q23.1 and q26.2) of chromosome 3. It is associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A78-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B5-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(3;12)(q23;p12.3)(ETV6/EVI1)","valueDescription":null,"ValueMeaning":{"publicId":"13336610","version":"1","preferredName":"t(3;12)(q23;p12.3)","longName":"13336610v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 3 and the short arm (p12.3) of chromosome 12. It is associated with ETV6/MECOM (EVI1) fusions, myeloproliferative disorders, myelodysplastic syndromes and acute myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;12)(q23;p12.3)","conceptCode":"C168766","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q23) of chromosome 3 and the short arm (p12.3) of chromosome 12. It is associated with ETV6/MECOM (EVI1) fusions, myeloproliferative disorders, myelodysplastic syndromes and acute myelogenous leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F9-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B6-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"del(5q)(5q31-q32)","valueDescription":null,"ValueMeaning":{"publicId":"13336598","version":"1","preferredName":"del(5q31-q32)","longName":"13336598v1.00","preferredDefinition":"A cytogenetic abnormality that refers to deletion of chromosome bands 31-32 on the long arm of chromosome 5.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"del(5q31-q32)","conceptCode":"C168769","definition":"A cytogenetic abnormality that refers to deletion of chromosome bands 31-32 on the long arm of chromosome 5.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B39-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B7-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(1;22)(RBM15-MKL1)","valueDescription":null,"ValueMeaning":{"publicId":"13336602","version":"1","preferredName":"t(1;22)(p13.3;q13.1)","longName":"13336602v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p13.3) of chromosome 1 and the long arm (q13.1) of chromosome 22. It is associated with RBM15/MRTFA (MKL1) fusions and acute megakaryocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;22)(p13.3;q13.1)","conceptCode":"C36417","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p13.3) of chromosome 1 and the long arm (q13.1) of chromosome 22. It is associated with RBM15/MRTFA (MKL1) fusions and acute megakaryocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3D-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B8-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"del(13q) (13q 14 - 21)","valueDescription":null,"ValueMeaning":{"publicId":"13336597","version":"1","preferredName":"del(13q14-q21)","longName":"13336597v1.00","preferredDefinition":"A cytogenetic abnormality that refers to deletion of chromosome bands 14-21 on the long arm of chromosome 13.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"del(13q14-q21)","conceptCode":"C168770","definition":"A cytogenetic abnormality that refers to deletion of chromosome bands 14-21 on the long arm of chromosome 13.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B38-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90B9-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"del(17p)","valueDescription":null,"ValueMeaning":{"publicId":"4534971","version":"1","preferredName":"Loss of Chromosome 17p","longName":"4534971","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the short arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 17p","conceptCode":"C36499","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 17 (17p).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05633FB3-FD67-B268-E050-BB89AD431E51","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9157757-90BA-037F-E053-731AD00AB84A","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FLT3-TKD","valueDescription":null,"ValueMeaning":{"publicId":"3925972","version":"1","preferredName":"Flt3 Ligand Point Mutation","longName":"3925972","preferredDefinition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Tyrosine Kinase Domain Point Mutation","conceptCode":"C67495","definition":"Single nucleotide mutations in the tyrosine kinase domain encoded by the human FLT3 gene that are associated with acute myeloid leukemia and poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9563CDD-9016-A3C4-E040-BB89AD431C3A","latestVersionIndicator":"Yes","beginDate":"2013-10-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D03-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CKIT mutation - ex17","valueDescription":null,"ValueMeaning":{"publicId":"5002154","version":"1","preferredName":"Seventeen KIT Gene Exon","longName":"5002154","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in exon 17 of the KIT gene located within 4q11-q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Exon 17 Mutation","conceptCode":"C116396","definition":"A molecular genetic abnormality indicating the presence of a mutation in exon 17 of the KIT gene located within 4q11-q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EF08B88-09CC-350D-E050-BB89AD434618","latestVersionIndicator":"Yes","beginDate":"2015-09-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-09-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D04-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Non-KMT2A MLLT10","valueDescription":null,"ValueMeaning":{"publicId":"13336600","version":"1","preferredName":"Non-KMT2A MLLT10 Rearrangement Positive","longName":"13336600v1.00","preferredDefinition":"An indication that a cytogenetic rearrangement involving MLLT10 but not involving KMT2A was detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-KMT2A MLLT10 Rearrangement Positive","conceptCode":"C168771","definition":"An indication that a cytogenetic rearrangement involving MLLT10 but not involving KMT2A was detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B3B-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D05-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"NPM1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13336596","version":"1","preferredName":"Monoallelic CEBPA Gene Mutation","longName":"13336596v1.00","preferredDefinition":"The presence of mutations in only one allele of the CEBPA gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monoallelic CEBPA Gene Mutation","conceptCode":"C168774","definition":"The presence of mutations in only one allele of the CEBPA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B37-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D06-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"WT1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6068728","version":"1","preferredName":"WT1 Gene Mutation","longName":"6068728","preferredDefinition":"A change in the nucleotide sequence of the WT1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WT1 Gene Mutation","conceptCode":"C146726","definition":"A change in the nucleotide sequence of the WT1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6519AB80-BED8-7F0F-E053-F662850A7B7E","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-02-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D07-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CKIT mutation - ex8","valueDescription":null,"ValueMeaning":{"publicId":"5002155","version":"1","preferredName":"Eight KIT Gene Exon","longName":"5002155","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Exon 8 Mutation","conceptCode":"C128660","definition":"A molecular genetic abnormality indicating the presence of a mutation in exon 8 of the KIT gene located within 4q11-q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1EF08B88-09F3-350D-E050-BB89AD434618","latestVersionIndicator":"Yes","beginDate":"2015-09-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-09-04","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D08-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CKIT mutation - unspecified","valueDescription":null,"ValueMeaning":{"publicId":"4514717","version":"1","preferredName":"KIT Gene Mutation","longName":"4514717","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7A18-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D09-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"GATA1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6450706","version":"1","preferredName":"GATA1 Gene Mutation","longName":"6450706","preferredDefinition":"A change in the nucleotide sequence of the GATA1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GATA1 Gene Mutation","conceptCode":"C82340","definition":"A change in the nucleotide sequence of the GATA1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76F29E01-0285-57FB-E053-F662850A7BC0","latestVersionIndicator":"Yes","beginDate":"2018-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0A-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"RUNX1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6438453","version":"1","preferredName":"RUNX1 Gene Mutation","longName":"6438453","preferredDefinition":"A change in the nucleotide sequence of the RUNX1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RUNX1 Gene Mutation","conceptCode":"C38362","definition":"A change in the nucleotide sequence of the RUNX1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76C9F568-A237-2E22-E053-F662850A228A","latestVersionIndicator":"Yes","beginDate":"2018-09-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0B-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"inv(16)(p13.3q24.3)/CBFA2T3-GLIS2","valueDescription":null,"ValueMeaning":{"publicId":"7292219","version":"1","preferredName":"inv(16)(p13.3;q24.3)","longName":"7292219","preferredDefinition":"A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(16)(p13.3;q24.3)","conceptCode":"C167195","definition":"A pericentric chromosomal inversion that involves chromosome 16. It is associated with CBFA2T3/GLIS2 fusions and pediatric acute megakaryoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A52-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"COLBERTM","dateModified":"2020-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0C-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;15)(p15;q35)/NUP98/JARID1A","valueDescription":null,"ValueMeaning":{"publicId":"13336604","version":"1","preferredName":"t(11;15)(p15;q35)","longName":"13336604v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 15q35. It results in the formation of NUP98/JARID1A fusion gene. It is associated with the development of acute myeloid leukemia with t(11;15)(p15;q35); NUP98-JARID1A.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;15)(p15;q35)","conceptCode":"C131505","definition":"A cytogenetic abnormality that refers to the translocation of chromosome 11p15 with chromosome 15q35. It results in the formation of NUP98/JARID1A fusion gene. It is associated with the development of acute myeloid leukemia with t(11;15)(p15;q35); NUP98-JARID1A.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F3-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0D-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(16;21)(q24;q22)RUNX1-CBFA2T3","valueDescription":null,"ValueMeaning":{"publicId":"13336608","version":"1","preferredName":"t(16;21)(q24;q22)","longName":"13336608v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q24) of chromosome 16 and the long arm (q22) of chromosome 22. It is associated with RUNX1/CBFA2T3 fusions, myelodysplastic syndromes and acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;21)(q24;q22)","conceptCode":"C168773","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q24) of chromosome 16 and the long arm (q22) of chromosome 22. It is associated with RUNX1/CBFA2T3 fusions, myelodysplastic syndromes and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE98B7-42F7-63DD-E053-731AD00A57C2","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0E-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(3;5)(p25;q34)NPM1/MLF1","valueDescription":null,"ValueMeaning":{"publicId":"7292216","version":"1","preferredName":"t(3;5)(q25;q34)","longName":"7292216","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the long arm (q25) of chromosome 3 and the long arm (q34) of chromosome 5. It is associated with the development of acute myeloid leukemia arising from myelodysplastic syndrome, acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(3;5)(q25;q34)","conceptCode":"C36415","definition":"A cytogenetic abnormality that refers to the translocation of the long arm (q25) of chromosome 3 and the long arm (q34) of chromosome 5. It is associated with the development of acute myeloid leukemia arising from myelodysplastic syndrome, acute myeloid leukemia with multilineage dysplasia, and acute myeloid leukemia with myelodysplasia-related changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-09E3-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D0F-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(16;21)(p11;q22)FUS/ERG","valueDescription":null,"ValueMeaning":{"publicId":"7292215","version":"1","preferredName":"t(16;21)(p11;q22)","longName":"7292215","preferredDefinition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;21)(p11;q22)","conceptCode":"C36616","definition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-09BE-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D10-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"MLL Other partner","valueDescription":null,"ValueMeaning":{"publicId":"3554905","version":"1","preferredName":"Translocation 11q23","longName":"3554905v1.00","preferredDefinition":"A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(v;11q23.3)","conceptCode":"C36517","definition":"A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C740F5C7-76D8-BDA9-E040-BB89AD434D2D","latestVersionIndicator":"Yes","beginDate":"2012-08-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-14","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D11-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CEBPA mutation - biallelic","valueDescription":null,"ValueMeaning":{"publicId":"6648963","version":"1","preferredName":"Biallelic CEBPA Gene Mutation","longName":"6648963","preferredDefinition":"The presence of mutations in both alleles of the CEBPA gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biallelic CEBPA Gene Mutation","conceptCode":"C157569","definition":"The presence of mutations in both alleles of the CEBPA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"822D97FE-719A-7DAB-E053-F662850A072D","latestVersionIndicator":"Yes","beginDate":"2019-02-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-02-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D12-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CEBPA mutation - mutation unspecified","valueDescription":null,"ValueMeaning":{"publicId":"6450506","version":"1","preferredName":"CEBPA Gene Mutation","longName":"6450506","preferredDefinition":"Mutation of the CEBPA gene encoding CCAAT/enhancer binding protein alpha. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CEBPA Gene Mutation","conceptCode":"C38372","definition":"Mutation of the CEBPA gene encoding CCAAT/enhancer binding protein alpha. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EF893C-D0EC-5805-E053-F662850A9F76","latestVersionIndicator":"Yes","beginDate":"2018-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-28","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D13-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FLT3 internal tandem duplication (ITD)","valueDescription":null,"ValueMeaning":{"publicId":"3630974","version":"1","preferredName":"FLT3 Internal Tandem Duplication","longName":"3630974","preferredDefinition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLT3 Internal Tandem Duplication","conceptCode":"C67494","definition":"A genetic abnormality that arises from duplications of the juxtamembrane portion of the gene and results in constitutive activation of the FLT3 receptor tyrosine kinase protein in early hematopoietic progenitor cells. It is associated with acute myelogenous leukemia where it appears to correlate with a poor prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF94B6E0-9B06-7FAD-E040-BB89AD433160","latestVersionIndicator":"Yes","beginDate":"2012-11-28","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915BE7B-6D14-0D6F-E053-731AD00A9B29","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(12;22)(q13.12;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343342","version":"1","preferredName":"t(12;22)(q13.12;q12)","longName":"13343342v1.00","preferredDefinition":"A chromosomal translocation involving the ATF1 gene at 12q13.12 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;22)(q13.12;q12)","conceptCode":"C174478","definition":"A chromosomal translocation involving the ATF1 gene at 12q13.12 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45D-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D467-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(2;22)(q34;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343343","version":"1","preferredName":"t(2;22)(q34;q12)","longName":"13343343v1.00","preferredDefinition":"A chromosomal translocation involving the CREB1 gene at 2q34 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;22)(q34;q12)","conceptCode":"C174481","definition":"A chromosomal translocation involving the CREB1 gene at 2q34 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45E-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D468-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(1;16)(p34;p11)","valueDescription":null,"ValueMeaning":{"publicId":"13343344","version":"1","preferredName":"t(1;16)(p34;p11)","longName":"13343344v1.00","preferredDefinition":"A chromosomal translocation involving the KLF17 gene at 1p34 and the FUS gene at 16p11.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;16)(p34;p11)","conceptCode":"C174475","definition":"A chromosomal translocation involving the KLF17 gene at 1p34 and the FUS gene at 16p11.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45F-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D469-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(12;16)(q13;p11)","valueDescription":null,"ValueMeaning":{"publicId":"4396472","version":"1","preferredName":"t(12;16)(q13;p11)","longName":"4396472","preferredDefinition":"A chromosomal translocation that involves chromosome 12 and chromosome 16. It is often associated with the development of angiomatoid fibrous histiocytoma or myxoid liposarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;16)(q13;p11)","conceptCode":"C36317","definition":"A chromosomal translocation that involves chromosome 12 and chromosome 16. It is often associated with the development of angiomatoid fibrous histiocytoma or myxoid liposarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FECEB4C2-80C2-358A-E040-BB89AD43152C","latestVersionIndicator":"Yes","beginDate":"2014-07-22","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-07-22","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46A-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(4;19)(q25;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13343345","version":"1","preferredName":"t(4;19)(q25;q13)","longName":"13343345v1.00","preferredDefinition":"A chromosomal translocation involving the CIC gene at 19q13 and a second breakpoint on the long arm of chromosome 4 (4q25).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(4;19)(q25;q13)","conceptCode":"C174482","definition":"A chromosomal translocation involving the CIC gene at 19q13 and a second breakpoint on the long arm of chromosome 4 (4q25).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D460-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46B-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(10;19)(q26;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13343347","version":"1","preferredName":"t(10;19)(q26;q13)","longName":"13343347v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4L (double homeobox 4-like) on chromosome 10 resulting in CIC-DUX4L fusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(10;19)(q26;q13)","conceptCode":"C120223","definition":"A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4L (double homeobox 4-like) on chromosome 10 resulting in CIC-DUX4L fusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D462-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46C-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"inv(X)(p11.4;p11.22)","valueDescription":null,"ValueMeaning":{"publicId":"13343348","version":"1","preferredName":"inv(X)(p11.4;p11.22)","longName":"13343348v1.00","preferredDefinition":"A paracentric chromosomal inversion of the short arm of the X chromosome involving the BCOR gene at Xp11.4 and the CCNB3 gene at Xp11.22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"inv(X)(p11.4;p11.22)","conceptCode":"C174489","definition":"A paracentric chromosomal inversion of the short arm of the X chromosome involving the BCOR gene at Xp11.4 and the CCNB3 gene at Xp11.22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D463-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46D-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(X;4)(p11;q31)","valueDescription":null,"ValueMeaning":{"publicId":"13343349","version":"1","preferredName":"t(X;4)(p11;q31)","longName":"13343349v1.00","preferredDefinition":"A chromosomal translocation involving the BCOR gene at Xp11 and the MAML3 gene at 4q31.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;4)(p11;q31)","conceptCode":"C174490","definition":"A chromosomal translocation involving the BCOR gene at Xp11 and the MAML3 gene at 4q31.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D464-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46E-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(X;22((p11;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13343350","version":"1","preferredName":"t(X;22)(p11;q13)","longName":"13343350v1.00","preferredDefinition":"A chromosomal translocation involving the BCOR gene at Xp11 and the ZC3H7B gene at 22q13.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;22)(p11;q13)","conceptCode":"C174495","definition":"A chromosomal translocation involving the BCOR gene at Xp11 and the ZC3H7B gene at 22q13.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D465-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D46F-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(9;17)(q22;q11)","valueDescription":null,"ValueMeaning":{"publicId":"13343351","version":"1","preferredName":"t(9;17)(q22;q11)","longName":"13343351v1.00","preferredDefinition":"A chromosomal translocation involving the NR4A3 gene on chromosome 9q31 and the TAF15 gene on chromosome 17q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;17)(q22;q11)","conceptCode":"C36393","definition":"A chromosomal translocation involving the NR4A3 gene on chromosome 9q31 and the TAF15 gene on chromosome 17q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D466-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D470-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(4;19)(q35;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13343346","version":"1","preferredName":"t(4;19)(q35;q13)","longName":"13343346v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4 (double homeobox 4) on chromosome 4 resulting in CIC-DUX4 fusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(4;19)(q35;q13)","conceptCode":"C120222","definition":"A cytogenetic abnormality that refers to the translocation involving the genes CIC (capicua transcriptional suppressor) on chromosome 19 and DUX4 (double homeobox 4) on chromosome 4 resulting in CIC-DUX4 fusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D461-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D471-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(6;22)(p21;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343337","version":"1","preferredName":"t(6;22)(p21;q12)","longName":"13343337v1.00","preferredDefinition":"A chromosomal translocation involving the POU5F1 gene at 6p21 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;22)(p21;q12)","conceptCode":"C174483","definition":"A chromosomal translocation involving the POU5F1 gene at 6p21 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D458-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D472-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(19;22)(q13;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343338","version":"1","preferredName":"t(19;22)(q13;q12)","longName":"13343338v1.00","preferredDefinition":"A chromosomal translocation involving the ZNF444 gene at 19q13 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(19;22)(q13;q12)","conceptCode":"C174480","definition":"A chromosomal translocation involving the ZNF444 gene at 19q13 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D459-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D473-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(1;22)(p34;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343339","version":"1","preferredName":"t(1;22)(p34;q12)","longName":"13343339v1.00","preferredDefinition":"A chromosomal translocation involving the KLF17 gene at 1p34 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;22)(p34;q12)","conceptCode":"C174476","definition":"A chromosomal translocation involving the KLF17 gene at 1p34 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45A-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D474-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(9;22)(q22;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343340","version":"1","preferredName":"t(9;22)(q22;q12)","longName":"13343340v1.00","preferredDefinition":"A chromosomal translocation involving the NR4A3 gene at 9q22 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;22)(q22;q12)","conceptCode":"C174484","definition":"A chromosomal translocation involving the NR4A3 gene at 9q22 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45B-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D475-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(12;22)(q13.3;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343341","version":"1","preferredName":"t(12;22)(q13.3;q12)","longName":"13343341v1.00","preferredDefinition":"A chromosomal translocation involving the DDIT3 gene at 12q13.3 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;22)(q13.3;q12)","conceptCode":"C174479","definition":"A chromosomal translocation involving the DDIT3 gene at 12q13.3 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D45C-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D476-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"N-RAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509092","version":"1","preferredName":"NRAS Gene Mutation","longName":"5509092","preferredDefinition":"A change in the structure of the NRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRAS Gene Mutation","conceptCode":"C41381","definition":"A change in the structure of the NRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E984DAC-540A-3B8C-E053-F662850ABB84","latestVersionIndicator":"Yes","beginDate":"2016-10-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D477-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"K-RAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"4514746","version":"1","preferredName":"KRAS Gene Mutation","longName":"4514746","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Gene Mutation","conceptCode":"C41361","definition":"A change in the nucleotide sequence of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7CD7-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D478-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;22)(q24;q12)","valueDescription":null,"ValueMeaning":{"publicId":"7653673","version":"1","preferredName":"t(11;22)(q24;q12)","longName":"7653673","preferredDefinition":"A chromosomal translocation involving the FLI1 gene on chromosome 11q24 and the EWSR1 gene on chromosome 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;22)(q24;q12)","conceptCode":"C27214","definition":"A chromosomal translocation involving the FLI1 gene on chromosome 11q24 and the EWSR1 gene on chromosome 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2247A9F-BF87-5DB9-E053-4EBD850A80D2","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D479-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(21;22)(q22;q12)","valueDescription":null,"ValueMeaning":{"publicId":"2672734","version":"1","preferredName":"t(21;22)(q22;q12)","longName":"2672734v1.00","preferredDefinition":"A chromosomal translocation associated with Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Olfactory Neuroblastoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(21;22)(q22;q12)","conceptCode":"C36367","definition":"A chromosomal translocation associated with Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Olfactory Neuroblastoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37BCDCA9-0AB7-297B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-15","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-15","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47A-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(7;22)(p22;q12)","valueDescription":null,"ValueMeaning":{"publicId":"7653668","version":"1","preferredName":"t(7;22)(p22;q12)","longName":"7653668","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p22) of chromosome 7 and the long arm (q12) of chromosome 22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(7;22)(p22;q12)","conceptCode":"C36368","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p22) of chromosome 7 and the long arm (q12) of chromosome 22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2247A9F-BF18-5DB9-E053-4EBD850A80D2","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47B-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(17;22)(q21;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343334","version":"1","preferredName":"t(17;22)(q21;q12)","longName":"13343334v1.00","preferredDefinition":"A chromosomal translocation involving the ETV4 gene on chromosome 17q21 and the EWSR1 gene on chromosome 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(17;22)(q21;q12)","conceptCode":"C36369","definition":"A chromosomal translocation involving the ETV4 gene on chromosome 17q21 and the EWSR1 gene on chromosome 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D455-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47C-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(2;22)(q33;q12)","valueDescription":null,"ValueMeaning":{"publicId":"7653670","version":"1","preferredName":"t(2;22)(q33;q12)","longName":"7653670","preferredDefinition":"A chromosomal translocation involving the CREB1 gene on chromosome 2q33 and the EWSR1 gene on chromosome 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;22)(q33;q12)","conceptCode":"C37249","definition":"A chromosomal translocation involving the CREB1 gene on chromosome 2q33 and the EWSR1 gene on chromosome 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2247A9F-BF3E-5DB9-E053-4EBD850A80D2","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47D-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(11;22)(p13;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343335","version":"1","preferredName":"t(11;22)(p13;q12)","longName":"13343335v1.00","preferredDefinition":"A chromosomal translocation involving the WT1 gene on chromosome 11p31 and the EWSR1 gene on chromosome 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;22)(p13;q12)","conceptCode":"C36375","definition":"A chromosomal translocation involving the WT1 gene on chromosome 11p31 and the EWSR1 gene on chromosome 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D456-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47E-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(1;22)(q23;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13343336","version":"1","preferredName":"t(1;22)(q23;q12)","longName":"13343336v1.00","preferredDefinition":"A chromosomal translocation involving the PBX1 gene at 1q23 and the EWSR1 gene at 22q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;22)(q23;q12)","conceptCode":"C174477","definition":"A chromosomal translocation involving the PBX1 gene at 1q23 and the EWSR1 gene at 22q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915ED46-D457-1EBE-E053-731AD00A98D5","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915ED46-D47F-1EBE-E053-731AD00A98D5","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-KLF17","valueDescription":null,"ValueMeaning":{"publicId":"13343356","version":"1","preferredName":"EWSR1/KLF17 Fusion Gene","longName":"13343356v1.00","preferredDefinition":"A rare fusion gene that results from a chromosomal translocation t(1;22)(p34;q12) which fuses portions of the EWSR1 gene with the 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/KLF17 Fusion Gene","conceptCode":"C174474","definition":"A rare fusion gene that results from a chromosomal translocation t(1;22)(p34;q12) which fuses portions of the EWSR1 gene with the 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E341-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E348-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-NR4A3","valueDescription":null,"ValueMeaning":{"publicId":"13343357","version":"1","preferredName":"EWSR1/NR4A3 Fusion Gene","longName":"13343357v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(9;22)(q22-31;q11-12) which fuses the first half of the EWSR1 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/NR4A3 Fusion Gene","conceptCode":"C99252","definition":"A fusion gene that results from a chromosomal translocation t(9;22)(q22-31;q11-12) which fuses the first half of the EWSR1 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E342-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E349-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-DDIT3","valueDescription":null,"ValueMeaning":{"publicId":"13343358","version":"1","preferredName":"EWSR1/DDIT3 Fusion Gene","longName":"13343358v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(12;22)(q13;p11) which fuses either the first 7 or the first 10 exons of the EWSR1 gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/DDIT3 Fusion Gene","conceptCode":"C99200","definition":"A fusion gene that results from a chromosomal translocation t(12;22)(q13;p11) which fuses either the first 7 or the first 10 exons of the EWSR1 gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E343-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34A-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-ATF1","valueDescription":null,"ValueMeaning":{"publicId":"5984821","version":"1","preferredName":"EWSR1/ATF1 Fusion Gene","longName":"5984821","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(12;22)(q13;q12) which fuses the first 7 or 8 exons of the EWSR1 gene on the 5' side of exon 4 or 5 of the ATF1 gene. This rearrangement is associated with both malignant clear cell sarcoma of the soft tissue and angiomatoid fibrous histiocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/ATF1 Fusion Gene","conceptCode":"C99216","definition":"A fusion gene that results from a chromosomal translocation t(12;22)(q13;q12) which fuses the first 7 or 8 exons of the EWSR1 gene on the 5' side of exon 4 or 5 of the ATF1 gene. This rearrangement is associated with both malignant clear cell sarcoma of the soft tissue and angiomatoid fibrous histiocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C0CC-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34B-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-CREB1","valueDescription":null,"ValueMeaning":{"publicId":"5984819","version":"1","preferredName":"EWSR1/CREB1 Fusion Gene","longName":"5984819","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(2;22)(q34;q12) which fuses the first 7 exons of the EWSR1 gene to the 5' side of exon 7 of the CREB1 gene. This rearrangement is associated with angiomatoid fibrous histiocytoma and rare cases of malignant clear cell sarcoma of the soft tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/CREB1 Fusion Gene","conceptCode":"C99249","definition":"A fusion gene that results from a chromosomal translocation t(2;22)(q34;q12) which fuses the first 7 exons of the EWSR1 gene to the 5' side of exon 7 of the CREB1 gene. This rearrangement is associated with angiomatoid fibrous histiocytoma and rare cases of malignant clear cell sarcoma of the soft tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C0A6-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34C-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CIC-DUX4","valueDescription":null,"ValueMeaning":{"publicId":"5984829","version":"1","preferredName":"CIC/DUX4 Fusion Gene","longName":"5984829","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(4;19)(q35;q13) which fuses exon 20 of the CIC gene to exon 1 of the DUX4 gene. This fusion is associated with soft tissue sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CIC/DUX4 Fusion Gene","conceptCode":"C139663","definition":"A fusion gene that results from a chromosomal translocation t(4;19)(q35;q13) which fuses exon 20 of the CIC gene to exon 1 of the DUX4 gene. This fusion is associated with soft tissue sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C188-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34D-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CCNB3-BCOR","valueDescription":null,"ValueMeaning":{"publicId":"5984828","version":"1","preferredName":"BCOR/CCNB3 Fusion Gene","longName":"5984828","preferredDefinition":"A fusion gene that results from a paracentric chromosomal inversion inv(X)(p11.4;p11.22) which fuses the stop codon of the BCOR gene to exon 5 of the CCNB3 gene. This fusion is associated with bone sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCOR/CCNB3 Fusion Gene","conceptCode":"C139666","definition":"A fusion gene that results from a paracentric chromosomal inversion inv(X)(p11.4;p11.22) which fuses the stop codon of the BCOR gene to exon 5 of the CCNB3 gene. This fusion is associated with bone sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C163-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34E-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"BCOR-MAML3","valueDescription":null,"ValueMeaning":{"publicId":"13343360","version":"1","preferredName":"BCOR/MAML3 Fusion Gene","longName":"13343360v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(X;4)(p11;q31) which fuses part of exon 15 of the BCOR gene in frame with exon 2 of the MAML3 gene. This fusion is associated with undifferentiated small blue round cell sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCOR/MAML3 Fusion Gene","conceptCode":"C174487","definition":"A fusion gene that results from a chromosomal translocation t(X;4)(p11;q31) which fuses part of exon 15 of the BCOR gene in frame with exon 2 of the MAML3 gene. This fusion is associated with undifferentiated small blue round cell sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E345-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E34F-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"ZC3H7B-BCOR","valueDescription":null,"ValueMeaning":{"publicId":"13343361","version":"1","preferredName":"ZC3H7B/BCOR Fusion Gene","longName":"13343361v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(X;22)(p11;q13) which fuses exon 10 of the ZC3H7B gene to either exon 7 or 8 of the BCOR gene. This fusion is associated with both undifferentiated small blue round cell sarcomas and endometrial stromal sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ZC3H7B/BCOR Fusion Gene","conceptCode":"C174491","definition":"A fusion gene that results from a chromosomal translocation t(X;22)(p11;q13) which fuses exon 10 of the ZC3H7B gene to either exon 7 or 8 of the BCOR gene. This fusion is associated with both undifferentiated small blue round cell sarcomas and endometrial stromal sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E346-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E350-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"TAF15-NR4A3","valueDescription":null,"ValueMeaning":{"publicId":"13343362","version":"1","preferredName":"TAF15/NR4A3 Fusion Gene","longName":"13343362v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(9;17)(q22;q11) which fuses exon 6 of the TAF15 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TAF15/NR4A3 Fusion Gene","conceptCode":"C99501","definition":"A fusion gene that results from a chromosomal translocation t(9;17)(q22;q11) which fuses exon 6 of the TAF15 gene to the entire coding sequence of the NR4A3 gene. This rearrangement is associated with extraskeletal myxoid chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E347-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E351-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS-KLF17","valueDescription":null,"ValueMeaning":{"publicId":"13343359","version":"1","preferredName":"FUS/KLF17 Fusion Gene","longName":"13343359v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(1;16)(p34;p11) which fuses either intron 4 or exon 6 of the FUS gene with 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS/KLF17 Fusion Gene","conceptCode":"C174473","definition":"A fusion gene that results from a chromosomal translocation t(1;16)(p34;p11) which fuses either intron 4 or exon 6 of the FUS gene with 5'-untranslated region of the KLF17 gene. This rearrangement is associated with myoepithelial tumors of soft tissue and bone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E344-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E352-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-FEV","valueDescription":null,"ValueMeaning":{"publicId":"13343354","version":"1","preferredName":"EWSR1/FEV Fusion Gene","longName":"13343354v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(2;22)(q36;q12) which fuses either the first seven or ten exons of the EWSR1 gene with exon 1 or 2 of the FEV gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/FEV Fusion Gene","conceptCode":"C99226","definition":"A fusion gene that results from a chromosomal translocation t(2;22)(q36;q12) which fuses either the first seven or ten exons of the EWSR1 gene with exon 1 or 2 of the FEV gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E33F-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E353-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-WT1","valueDescription":null,"ValueMeaning":{"publicId":"13343355","version":"1","preferredName":"EWSR1/WT1 Fusion Gene","longName":"13343355v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(11;22)(p13;q12) which fuses the intron between exons 7 and 8 of the EWSR1 gene with the intron between exons 7 and 8 of the WT1 gene. This rearrangement is associated with desmoplastic small round cell sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/WT1 Fusion Gene","conceptCode":"C99213","definition":"A fusion gene that results from a chromosomal translocation t(11;22)(p13;q12) which fuses the intron between exons 7 and 8 of the EWSR1 gene with the intron between exons 7 and 8 of the WT1 gene. This rearrangement is associated with desmoplastic small round cell sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E340-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E354-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-PBX1","valueDescription":null,"ValueMeaning":{"publicId":"5984817","version":"1","preferredName":"EWSR1/PBX1 Fusion Gene","longName":"5984817","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(1;22)(q23;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the PBX1 gene. This fusion may be associated with myoepithelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/PBX1 Fusion Gene","conceptCode":"C139668","definition":"A fusion gene that results from a chromosomal translocation t(1;22)(q23;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the PBX1 gene. This fusion may be associated with myoepithelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C080-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E355-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-POU5F1","valueDescription":null,"ValueMeaning":{"publicId":"5984815","version":"1","preferredName":"EWSR1/POU5F1 Fusion Gene","longName":"5984815","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(6;22)(p21;q12) which fuses the first six exons of the EWSR1 gene to exon 2 of the POU5F1 gene. This rearrangement is associated with hidradenoma and one case of mucoepidermoid carcinoma of the salivary glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/POU5F1 Fusion Gene","conceptCode":"C99256","definition":"A fusion gene that results from a chromosomal translocation t(6;22)(p21;q12) which fuses the first six exons of the EWSR1 gene to exon 2 of the POU5F1 gene. This rearrangement is associated with hidradenoma and one case of mucoepidermoid carcinoma of the salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C036-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E356-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-ZNF444","valueDescription":null,"ValueMeaning":{"publicId":"5984816","version":"1","preferredName":"EWSR1/ZNF444 Fusion Gene","longName":"5984816","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(19;22)(q13;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the ZNF444 gene. This fusion may be associated with myoepithelioma. (attr COSMIC and Atlas of Genetics and Cytogenetics in Oncology and Haematology)\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/ZNF444 Fusion Gene","conceptCode":"C139731","definition":"A fusion gene that results from a chromosomal translocation t(19;22)(q13;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the ZNF444 gene. This fusion may be associated with myoepithelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C05B-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E357-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"PTPN11 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5907475","version":"1","preferredName":"PTPN11 Gene Mutation","longName":"5907475","preferredDefinition":"Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PTPN11 Gene Mutation","conceptCode":"C82612","definition":"Mutation of the protein tyrosine phosphatase, non-receptor type 11 gene. It is seen in cases of juvenile myelomonocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54226B98-B9DD-5F1A-E053-F662850AE2A6","latestVersionIndicator":"Yes","beginDate":"2017-07-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-07-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E358-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E359-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-FLI1","valueDescription":null,"ValueMeaning":{"publicId":"6154484","version":"1","preferredName":"EWSR1/FLI1 Fusion Gene","longName":"6154484","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(11;22)(q24;q12) which fuses the first seven or ten exons of the EWSR1 gene with exon 5, 6 or 8 of the FLI1 gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/FLI1 Fusion Gene","conceptCode":"C99202","definition":"A fusion gene that results from a chromosomal translocation t(11;22)(q24;q12) which fuses the first seven or ten exons of the EWSR1 gene with exon 5, 6 or 8 of the FLI1 gene. This rearrangement is associated with Ewing tumor/peripheral primitive neuroectodermal tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"686CEB4C-2F8F-7DEF-E053-F662850A125C","latestVersionIndicator":"Yes","beginDate":"2018-03-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-27","modifiedBy":"ONEDATA","dateModified":"2018-03-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35A-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"TP53","valueDescription":null,"ValueMeaning":{"publicId":"4535603","version":"1","preferredName":"TP53 Gene Mutation","longName":"4535603","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32D5-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35B-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"STAG2","valueDescription":null,"ValueMeaning":{"publicId":"6424548","version":"1","preferredName":"STAG2 Gene Mutation","longName":"6424548","preferredDefinition":"A change in the nucleotide sequence of the STAG2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"STAG2 Gene Mutation","conceptCode":"C153513","definition":"A change in the nucleotide sequence of the STAG2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7533D911-2B68-27D3-E053-F662850A539F","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-09-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35C-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CDKN2A","valueDescription":null,"ValueMeaning":{"publicId":"5509117","version":"1","preferredName":"CDKN2A Gene Mutation","longName":"5509117","preferredDefinition":"A change in the nucleotide sequence of the CDKN2A gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A Gene Mutation","conceptCode":"C128817","definition":"A change in the nucleotide sequence of the CDKN2A gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E98A363-8D18-7B69-E053-F662850AC04B","latestVersionIndicator":"Yes","beginDate":"2016-10-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35D-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CIC-DUX4L10","valueDescription":null,"ValueMeaning":{"publicId":"13343353","version":"1","preferredName":"CIC/DUX4L10 Fusion Gene","longName":"13343353v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(10;19)(q26;q13) which fuses the CIC gene to the DUX4L10 gene, a pseudogene that is member of the DUX4L gene family cluster found at 10q26. This fusion is associated with the CIC-rearranged small blue round cell subtype of soft tissue sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CIC/DUX4L10 Fusion Gene","conceptCode":"C174463","definition":"A fusion gene that results from a chromosomal translocation t(10;19)(q26;q13) which fuses the CIC gene to the DUX4L10 gene, a pseudogene that is member of the DUX4L gene family cluster found at 10q26. This fusion is associated with the CIC-rearranged small blue round cell subtype of soft tissue sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F915FF7E-E33E-2183-E053-731AD00A7AD1","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35E-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-ERG","valueDescription":null,"ValueMeaning":{"publicId":"7639032","version":"1","preferredName":"EWSR1/ERG Fusion Gene","longName":"7639032","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(21;22)(q21;q12) which fuses the EWSR1 gene with the ERG gene. This rearrangement is associated with both Ewing tumor/peripheral primitive neuroectodermal tumor and desmoplastic small round cell sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/ERG Fusion Gene","conceptCode":"C99211","definition":"A fusion gene that results from a chromosomal translocation t(21;22)(q21;q12) which fuses the EWSR1 gene with the ERG gene. This rearrangement is associated with both Ewing tumor/peripheral primitive neuroectodermal tumor and desmoplastic small round cell sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0594F59-96F1-37F9-E053-4EBD850A2B88","latestVersionIndicator":"Yes","beginDate":"2021-04-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-04-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E35F-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-ETV1","valueDescription":null,"ValueMeaning":{"publicId":"5984827","version":"1","preferredName":"EWSR1/ETV1 Fusion Gene","longName":"5984827","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(7;22)(p22;q12) which fuses exon 7 of the EWSR1 gene to either exon 10 or 11 of the ETV1 gene. This rearrangement is associated with Ewing sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/ETV1 Fusion Gene","conceptCode":"C99259","definition":"A fusion gene that results from a chromosomal translocation t(7;22)(p22;q12) which fuses exon 7 of the EWSR1 gene to either exon 10 or 11 of the ETV1 gene. This rearrangement is associated with Ewing sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C13E-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E360-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1-ETV4","valueDescription":null,"ValueMeaning":{"publicId":"5984825","version":"1","preferredName":"EWSR1/ETV4 Fusion Gene","longName":"5984825","preferredDefinition":"A fusion gene (~2.1 kb) that results from a chromosomal translocation t(17;22)(q21;q12) which fuses the first seven exons of the EWSR1 gene to the last 6 exons of the ETV4 gene. This rearrangement is associated with Ewing sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1/ETV4 Fusion Gene","conceptCode":"C99262","definition":"A fusion gene (~2.1 kb) that results from a chromosomal translocation t(17;22)(q21;q12) which fuses the first seven exons of the EWSR1 gene to the last 6 exons of the ETV4 gene. This rearrangement is associated with Ewing sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A7E6059-C118-712E-E053-F662850A79FF","latestVersionIndicator":"Yes","beginDate":"2017-10-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F915FF7E-E361-2183-E053-731AD00A7AD1","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS-DDIT3","valueDescription":null,"ValueMeaning":{"publicId":"13343389","version":"1","preferredName":"FUS/DDIT3 Fusion Gene","longName":"13343389v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(12;16)(q13;p11) which fuses either the first 5, 7 or 8 exons of the FUS gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS/DDIT3 Fusion Gene","conceptCode":"C99279","definition":"A fusion gene that results from a chromosomal translocation t(12;16)(q13;p11) which fuses either the first 5, 7 or 8 exons of the FUS gene with exon 2 of the DDIT3 gene. This rearrangement is associated with myxoid liposarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BA2-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BA6-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"45XO","valueDescription":null,"ValueMeaning":{"publicId":"3211505","version":"1","preferredName":"Turner Syndrome","longName":"3211505","preferredDefinition":"A gonadal dysgenesis syndrome occurring in phenotypic females, characterized by the absence of a part or all of one of the sex chromosomes. Signs and symptoms include short stature, webbing of neck, low-set ears, hypogonadism, and sterility.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Turner Syndrome","conceptCode":"C26900","definition":"A gonadal dysgenesis syndrome occurring in phenotypic females, characterized by the absence of a part or all of one of the sex chromosomes. Signs and symptoms include short stature, webbing of neck, low-set ears, hypogonadism, and sterility.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-07D5-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BA7-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"45XO w/ Y chromosomal material","valueDescription":null,"ValueMeaning":{"publicId":"13343390","version":"1","preferredName":"45,XO with Y Chromosomal Material","longName":"13343390v1.00","preferredDefinition":"An abnormal sex chromosome karyotype where the individual is missing a second X chromosome and has some chromosomal material from the Y chromosome. The normal autosomal karyotype is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"45,XO with Y Chromosomal Material","conceptCode":"C176781","definition":"An abnormal sex chromosome karyotype where the individual is missing a second X chromosome and has some chromosomal material from the Y chromosome. The normal autosomal karyotype is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BA3-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BA8-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"46XX","valueDescription":null,"ValueMeaning":{"publicId":"13343391","version":"1","preferredName":"46,XX Gonadal Dysgenesis","longName":"13343391v1.00","preferredDefinition":"Gonadal dysgenesis in an individual with 46,XX karyotype and female phenotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"46,XX Gonadal Dysgenesis","conceptCode":"C120197","definition":"Gonadal dysgenesis in an individual with 46,XX karyotype and female phenotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BA4-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BA9-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"46XY","valueDescription":null,"ValueMeaning":{"publicId":"13343392","version":"1","preferredName":"46,XY Gonadal Dysgenesis","longName":"13343392v1.00","preferredDefinition":"Gonadal dysgenesis in an individual with 46.XY karyotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"46,XY Gonadal Dysgenesis","conceptCode":"C120198","definition":"Gonadal dysgenesis in an individual with 46.XY karyotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BA5-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BAA-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"47XYY","valueDescription":null,"ValueMeaning":{"publicId":"3211540","version":"1","preferredName":"XYY Syndrome","longName":"3211540","preferredDefinition":"A rare syndrome affecting males. It is characterized by the presence of an extra Y chromosome. Individuals with this disorder are taller than other males of their age. Signs and symptoms include learning disabilities and difficulties with speech and language development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"47,XYY Syndrome","conceptCode":"C85237","definition":"A condition caused by the presence of an extra Y chromosome resulting in 47,XYY karyotype in an individual with male phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language. Testicular function and size are normal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0CE5-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BAB-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"47XXY","valueDescription":null,"ValueMeaning":{"publicId":"3686764","version":"1","preferredName":"Klinefelter Syndrome","longName":"3686764","preferredDefinition":"A SEX CHROMOSOME DISORDER characterized by small testes, underdevelopment of secondary sexual characteristics, infertility (INFERTILITY, MALE), hyalinization and fibrosis of the seminiferous tubules, and elevated levels of gonadotropin. Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several variants include those with the karyotypes 48,XXYY; 48,XXXY; 49,XXXXY, and several mosaic patterns (46,XY/47,XXY; 47,XXY/48,XXXY, etc.).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Klinefelter Syndrome","conceptCode":"C34752","definition":"A sex chromosome disorder caused by the presence of an extra X chromosome in the male karyotype. Affected individuals are infertile and have a small penis and testes. They tend to have tall stature and long legs and may have difficulties with speech and language development. Gynecomastia may be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C88682-4840-08DD-E040-BB89AD430BDF","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2013-02-15","modifiedBy":"ONEDATA","dateModified":"2013-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BAC-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"47XXX","valueDescription":null,"ValueMeaning":{"publicId":"13343394","version":"1","preferredName":"47,XXX Syndrome","longName":"13343394v1.00","preferredDefinition":"A condition caused by the presence of an extra X chromosome resulting in 47,XXX karyotype in an individual with female phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"47,XXX Syndrome","conceptCode":"C129718","definition":"A condition caused by the presence of an extra X chromosome resulting in 47,XXX karyotype in an individual with female phenotype. The condition is characterized by tall stature, increased risk of learning disabilities, and delayed development of speech and language.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BAD-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BAF-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"48XXXY","valueDescription":null,"ValueMeaning":{"publicId":"3686771","version":"1","preferredName":"XXXY Syndrome","longName":"3686771","preferredDefinition":"A rare sex chromosome abnormality in which a male child has 2 extra X chromosomes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"XXXY Syndrome","conceptCode":"C89799","definition":"A rare sex chromosome abnormality in which a male child has 2 extra X chromosomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C88682-495C-08DD-E040-BB89AD430BDF","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2013-02-15","modifiedBy":"ONEDATA","dateModified":"2013-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB0-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"48XXXX","valueDescription":null,"ValueMeaning":{"publicId":"13343395","version":"1","preferredName":"48,XXXX Karyotype","longName":"13343395v1.00","preferredDefinition":"An abnormal sex chromosome karyotype where the individual has four copies of the X chromosome. The normal autosomal karyotype is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"48,XXXX Karyotype","conceptCode":"C176787","definition":"An abnormal sex chromosome karyotype where the individual has four copies of the X chromosome. The normal autosomal karyotype is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BAE-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB1-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB2-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(6;9)(p23;q34) DEK/NUP214","valueDescription":null,"ValueMeaning":{"publicId":"7292218","version":"1","preferredName":"t(6;9)(p23;q34.1)","longName":"7292218v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the translocation of the short arm (p23) of chromosome 6 and the long arm (q34.1) of chromosome 9. It is associated with DEK/NUP214 fusions, acute myeloid leukemia and myelodysplastic syndromes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(6;9)(p22.3;q34.1)","conceptCode":"C36532","definition":"A cytogenetic abnormality that refers to the translocation of the short arm (p22.3) of chromosome 6 and the long arm (q34.1) of chromosome 9. It is associated with DEK/NUP214 fusions, acute myeloid leukemia and myelodysplastic syndromes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-0A2D-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB4-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Chromosome 11 Loss","valueDescription":null,"ValueMeaning":{"publicId":"6885525","version":"1","preferredName":"Loss of Chromosome 11","longName":"6885525","preferredDefinition":"A cytogenic abnormality that refers to loss of all or part of chromosome 11.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 11","conceptCode":"C36549","definition":"A cytogenetic abnormality that refers to loss of all or part of chromosome 11.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91AB6009-8694-062E-E053-F662850A6B22","latestVersionIndicator":"Yes","beginDate":"2019-09-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-09-03","modifiedBy":"COLBERTM","dateModified":"2019-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB5-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Chromosome 14q Loss","valueDescription":null,"ValueMeaning":{"publicId":"3654259","version":"1","preferredName":"Loss of Chromosome 14q","longName":"3654259v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 14 (14q).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 14q","conceptCode":"C39795","definition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 14 (14q).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3F4C852-5642-56F0-E040-BB89AD433A6B","latestVersionIndicator":"Yes","beginDate":"2013-01-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-23","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BB9-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CTNNB1 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"6132236","version":"1","preferredName":"CTNNB1 Gene Mutation","longName":"6132236","preferredDefinition":"A change in the nucleotide sequence of the CTNNB1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTNNB1 Gene Mutation","conceptCode":"C36659","definition":"A change in the nucleotide sequence of the CTNNB1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6738C04F-B5C4-0AC9-E053-F662850A9B3A","latestVersionIndicator":"Yes","beginDate":"2018-03-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-03-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBA-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"MYC Amplification","valueDescription":null,"ValueMeaning":{"publicId":"5629232","version":"1","preferredName":"MYC Gene Amplification","longName":"5629232","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYC gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYC Gene Amplification","conceptCode":"C36641","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4660FED2-272F-2E94-E053-F662850A4700","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBB-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"PTCH1 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5782124","version":"1","preferredName":"PTCH1 Gene Mutation","longName":"5782124","preferredDefinition":"A change in the nucleotide sequence of the PTCH1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PTCH1 Gene Mutation","conceptCode":"C133669","definition":"A change in the nucleotide sequence of the PTCH1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E132C83-F384-570C-E053-F662850A027B","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBC-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"SMO Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509671","version":"1","preferredName":"SMO Gene Mutation","longName":"5509671","preferredDefinition":"A molecular genetic abnormality that refers to the mutation of the SMO gene located on chromosome 7q32.3.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SMO Gene Mutation","conceptCode":"C124793","definition":"A molecular genetic abnormality that refers to the mutation of the SMO gene located on chromosome 7q32.3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EAD813D-E7C5-61D2-E053-F662850A835B","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBD-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"SUFU Mutation","valueDescription":null,"ValueMeaning":{"publicId":"13343396","version":"1","preferredName":"SUFU Gene Mutation","longName":"13343396v1.00","preferredDefinition":"A change in the nucleotide sequence of the SUFU gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SUFU Gene Mutation","conceptCode":"C189843","definition":"A change in the nucleotide sequence of the SUFU gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BB7-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBE-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"TP53 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"4535603","version":"1","preferredName":"TP53 Gene Mutation","longName":"4535603","preferredDefinition":"A change in the nucleotide sequence of the TP53 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TP53 Gene Mutation","conceptCode":"C118396","definition":"A change in the nucleotide sequence of the TP53 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32D5-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BBF-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(2;16)(q35;p11)","valueDescription":null,"ValueMeaning":{"publicId":"13343397","version":"1","preferredName":"t(2;16)(q35;p11)","longName":"13343397v1.00","preferredDefinition":"A chromosomal translocation involving the FEV gene at 2q35 and the FUS gene at 16p11.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;16)(q35;p11)","conceptCode":"C174465","definition":"A chromosomal translocation involving the FEV gene at 2q35 and the FUS gene at 16p11.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F91624A6-8BB8-25F8-E053-731AD00A68EC","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BC0-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"12q Gain","valueDescription":null,"ValueMeaning":{"publicId":"3773534","version":"1","preferredName":"Gain of Chromosome 12q","longName":"3773534v1.00","preferredDefinition":"A chromosomal aberration where there are 3 copies of the long arm of chromosome 12. This aberration is associated with 12q duplication syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gain of Chromosome 12q","conceptCode":"C36441","definition":"A chromosomal aberration where there are 3 copies of the long arm of chromosome 12. This aberration is associated with 12q duplication syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DDEFF94D-50E5-D822-E040-BB89AD432DCE","latestVersionIndicator":"Yes","beginDate":"2013-05-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2013-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F91624A6-8BC1-25F8-E053-731AD00A68EC","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"16q Loss","valueDescription":null,"ValueMeaning":{"publicId":"13343398","version":"1","preferredName":"Loss of Chromosome 16q","longName":"13343398v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 16 (16q).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 16q","conceptCode":"C36515","definition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 16 (16q).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79B5-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79BB-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"1q Gain","valueDescription":null,"ValueMeaning":{"publicId":"5540275","version":"1","preferredName":"Gain of Chromosome 1q","longName":"5540275","preferredDefinition":"A cytogenetic abnormality that refers to allelic gain within the chromosomal arm 1q.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gain of Chromosome 1q","conceptCode":"C36482","definition":"A cytogenetic abnormality that refers to allelic gain within the chromosomal arm 1q.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F0D5-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79BC-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"8q Gain","valueDescription":null,"ValueMeaning":{"publicId":"13343399","version":"1","preferredName":"Gain of Chromosome 8q","longName":"13343399v1.00","preferredDefinition":"A chromosomal abnormality that refers to the gain of genetic material in the long arm of chromosome 8.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gain of Chromosome 8q","conceptCode":"C36488","definition":"A chromosomal abnormality that refers to the gain of genetic material in the long arm of chromosome 8.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79B6-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79BD-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CIC Rearranged","valueDescription":null,"ValueMeaning":{"publicId":"13343401","version":"1","preferredName":"CIC Gene Rearrangement","longName":"13343401v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the CIC gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CIC Gene Rearrangement","conceptCode":"C165668","definition":"A molecular abnormality indicating rearrangement of the CIC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79B8-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79BE-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"EWSR1 Rearranged","valueDescription":null,"ValueMeaning":{"publicId":"13343402","version":"1","preferredName":"EWSR1 Gene Rearrangement","longName":"13343402v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the EWSR1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EWSR1 Gene Rearrangement","conceptCode":"C165667","definition":"A molecular abnormality indicating rearrangement of the EWSR1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79B9-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79BF-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS Rearranged","valueDescription":null,"ValueMeaning":{"publicId":"13343403","version":"1","preferredName":"FUS Gene Rearrangement","longName":"13343403v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the FUS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS Gene Rearrangement","conceptCode":"C174462","definition":"A molecular abnormality indicating rearrangement of the FUS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79BA-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79C0-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"BCOR Rearranged","valueDescription":null,"ValueMeaning":{"publicId":"13343400","version":"1","preferredName":"BCOR Gene Rearrangement","longName":"13343400v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the BCOR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCOR Gene Rearrangement","conceptCode":"C174461","definition":"A molecular abnormality indicating rearrangement of the BCOR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162CD6-79B7-2761-E053-731AD00A8B7F","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162CD6-79C1-2761-E053-731AD00A8B7F","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS Translocation Present","valueDescription":null,"ValueMeaning":{"publicId":"7155602","version":"1","preferredName":"FUS Gene Translocation","longName":"7155602","preferredDefinition":"A cytogenetic abnormality that refers to any translocation involving the FUS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS Gene Translocation","conceptCode":"C168530","definition":"A cytogenetic abnormality that refers to any translocation involving the FUS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D4CF343-041E-6CCA-E053-F662850ABF32","latestVersionIndicator":"Yes","beginDate":"2020-01-29","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-01-29","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162EF8-0446-279D-E053-731AD00AC4B8","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS-ERG","valueDescription":null,"ValueMeaning":{"publicId":"13343404","version":"1","preferredName":"FUS/ERG Fusion Gene","longName":"13343404v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(16;21)(p11;q22) which fuses the FUS gene with the ERG gene. This rearrangement is associated with acute myeloid leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS/ERG Fusion Gene","conceptCode":"C99281","definition":"A fusion gene that results from a chromosomal translocation t(16;21)(p11;q22) which fuses the FUS gene with the ERG gene. This rearrangement is associated with acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162EF8-0444-279D-E053-731AD00AC4B8","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162EF8-0447-279D-E053-731AD00AC4B8","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"FUS-FEV","valueDescription":null,"ValueMeaning":{"publicId":"13343405","version":"1","preferredName":"FUS/FEV Fusion Gene","longName":"13343405v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(2;16)(q35;p11) which fuses exon 10 of the FUS gene with exon 2 of the FEV gene. This rearrangement is associated with Ewing sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS/FEV Fusion Gene","conceptCode":"C174466","definition":"A fusion gene that results from a chromosomal translocation t(2;16)(q35;p11) which fuses exon 10 of the FUS gene with exon 2 of the FEV gene. This rearrangement is associated with Ewing sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162EF8-0445-279D-E053-731AD00AC4B8","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162EF8-0448-279D-E053-731AD00AC4B8","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"t(16;21)(p11;q22)","valueDescription":null,"ValueMeaning":{"publicId":"7292215","version":"1","preferredName":"t(16;21)(p11;q22)","longName":"7292215","preferredDefinition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(16;21)(p11;q22)","conceptCode":"C36616","definition":"A chromosomal translocation involving the FUS gene on chromosome 16p11 and the ERG gene on chromosome 21q22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58CF713-09BE-2632-E053-F662850ABD95","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-05-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9162EF8-0449-279D-E053-731AD00AC4B8","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"NPM1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509772","version":"1","preferredName":"NPM1 Gene Mutation","longName":"5509772","preferredDefinition":"Mutation of the nucleophosmin gene. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NPM1 Gene Mutation","conceptCode":"C82429","definition":"Mutation of the nucleophosmin gene. It is seen in acute myeloid leukemias usually associated with a normal karyotype.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EAE8FC9-F8B7-6B59-E053-F662850AD453","latestVersionIndicator":"Yes","beginDate":"2016-10-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F916646B-04AC-3258-E053-731AD00A326A","beginDate":"2023-04-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-11","modifiedBy":"COLBERTM","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"CEBPA mutation - monoallelic","valueDescription":null,"ValueMeaning":{"publicId":"13336596","version":"1","preferredName":"Monoallelic CEBPA Gene Mutation","longName":"13336596v1.00","preferredDefinition":"The presence of mutations in only one allele of the CEBPA gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Monoallelic CEBPA Gene Mutation","conceptCode":"C168774","definition":"The presence of mutations in only one allele of the CEBPA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8FE90FD-2B37-62F6-E053-731AD00AC5F6","latestVersionIndicator":"Yes","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB809737-3DB1-751E-E053-731AD00A7EDA","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"t(X;17)(p11.2;q25)","valueDescription":null,"ValueMeaning":{"publicId":"7653675","version":"1","preferredName":"t(X;17)(p11.2;q25)","longName":"7653675","preferredDefinition":"A chromosomal translocation involving the TFE3 gene on chromosome Xp11.2 and the ASPSCR1 gene on chromosome 17q25.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;17)(p11.2;q25)","conceptCode":"C36392","definition":"A chromosomal translocation involving the TFE3 gene on chromosome Xp11.2 and the ASPSCR1 gene on chromosome 17q25.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C2247A9F-BFAD-5DB9-E053-4EBD850A80D2","latestVersionIndicator":"Yes","beginDate":"2021-05-12","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-12","modifiedBy":"ONEDATA","dateModified":"2021-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB8116D6-929A-0A72-E053-731AD00A0B08","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"t(12;22)(q13;q12)","valueDescription":null,"ValueMeaning":{"publicId":"5654914","version":"1","preferredName":"t(12;22)(q13;q12)","longName":"5654914","preferredDefinition":"A cytogenetic abnormality that refers to the a translocation involving the long arm (q13) of chromosome 12 and the long arm (q12) of chromosome 22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;22)(q13;q12)","conceptCode":"C36374","definition":"A cytogenetic abnormality that refers to the a translocation involving the long arm (q13) of chromosome 12 and the long arm (q12) of chromosome 22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47E1D321-51DD-5A79-E053-F662850A5552","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-02-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB812020-2965-0BB3-E053-731AD00A9817","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"t(17;22)(q22;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13569876","version":"1","preferredName":"t(17;22)(q22;q13)","longName":"13569876v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q22) of chromosome 17 and the long arm (q13) of chromosome 22. It is associated with the expression of COL1A1/PDGFB fusions and most if not all cases of dermatofibrosarcoma protuberans (DFSP).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(17;22)(q22;q13)","conceptCode":"C36520","definition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q22) of chromosome 17 and the long arm (q13) of chromosome 22. It is associated with the expression of COL1A1/PDGFB fusions and most if not all cases of dermatofibrosarcoma protuberans (DFSP).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB8124CD-EC15-0C51-E053-731AD00ACEEA","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB8124CD-EC16-0C51-E053-731AD00ACEEA","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"t(12;15)(p13;q25)","valueDescription":null,"ValueMeaning":{"publicId":"13569877","version":"1","preferredName":"t(12;15)(p13;q25)","longName":"13569877v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;15)(p13;q25)","conceptCode":"C36387","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB813988-AD61-0F1E-E053-731AD00A9D7E","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB813988-AD62-0F1E-E053-731AD00A9D7E","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"Complex karyotype","valueDescription":null,"ValueMeaning":{"publicId":"13569878","version":"1","preferredName":"Complex Karyotype","longName":"13569878v1.00","preferredDefinition":"Karyotype with at least three chromosomal aberrations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complex Karyotype","conceptCode":"C97138","definition":"Karyotype with at least three chromosomal aberrations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FB813E1C-74DD-0F98-E053-731AD00AB2A5","latestVersionIndicator":"Yes","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FB813E1C-74DE-0F98-E053-731AD00AB2A5","beginDate":"2023-05-12","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-12","modifiedBy":"FINCHAMB","dateModified":"2023-05-12","deletedIndicator":"No"},{"value":"11q Deletion","valueDescription":null,"ValueMeaning":{"publicId":"5629221","version":"1","preferredName":"Loss of Chromosome 11q","longName":"5629221","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the long arm of chromosome 11.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 11q","conceptCode":"C37312","definition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 11 (11q).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4660FED2-2571-2E94-E053-F662850A4700","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBC8BA8-919B-20E1-E053-731AD00AB08D","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"1p Deletion","valueDescription":null,"ValueMeaning":{"publicId":"3227260","version":"1","preferredName":"Loss of Chromosome 1p","longName":"3227260","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of the chromosomal arm 1p. It has been described in gliomas, meningiomas, neuroblastomas, hepatocellular carcinomas, breast carcinomas, acinar prostate adenocarcinomas, pancreatic carcinomas, and adrenal gland adenomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 1p","conceptCode":"C36501","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 1 (1p). It has been described in gliomas, meningiomas, neuroblastomas, hepatocellular carcinomas, breast carcinomas, acinar prostate adenocarcinomas, pancreatic carcinomas, and adrenal gland adenomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-95EA-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCA161-4065-231D-E053-731AD00A0C98","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"ALK Rearrangement","valueDescription":null,"ValueMeaning":{"publicId":"5540280","version":"1","preferredName":"ALK Gene Rearrangement","longName":"5540280","preferredDefinition":"A molecular abnormality indicating rearrangement of the ALK gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Gene Rearrangement","conceptCode":"C129574","definition":"A molecular abnormality indicating rearrangement of the ALK gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F146-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCBBBA-18DD-3294-E053-731AD00A99C3","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"t(7;16)(q33;p11)","valueDescription":null,"ValueMeaning":{"publicId":"13571084","version":"1","preferredName":"t(7;16)(q33;p11)","longName":"13571084v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q33) of chromosome 7 and the short arm (p11) of chromosome 16. It is associated with the expression of FUS/CREB3L2 fusions and is a characteristic feature of low grade fibromyxoid sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(7;16)(q33;p11)","conceptCode":"C45206","definition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q33) of chromosome 7 and the short arm (p11) of chromosome 16. It is associated with the expression of FUS/CREB3L2 fusions and is a characteristic feature of low grade fibromyxoid sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBCC691-D064-33D4-E053-731AD00A384F","latestVersionIndicator":"Yes","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCC691-D065-33D4-E053-731AD00A384F","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"ATM mutation","valueDescription":null,"ValueMeaning":{"publicId":"5607991","version":"1","preferredName":"ATM Gene Mutation","longName":"5607991","preferredDefinition":"A change in the nucleotide sequence of the ATM gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ATM Gene Mutation","conceptCode":"C40459","definition":"A change in the nucleotide sequence of the ATM gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44089E67-D6E8-243D-E053-F662850A51D9","latestVersionIndicator":"Yes","beginDate":"2016-12-19","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-12-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCE7A6-083B-38A0-E053-731AD00A4F58","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"BCOR mutation","valueDescription":null,"ValueMeaning":{"publicId":"6384496","version":"1","preferredName":"BCOR Gene Mutation","longName":"6384496","preferredDefinition":"A change in the nucleotide sequence of the BCOR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCOR Gene Mutation","conceptCode":"C153113","definition":"A change in the nucleotide sequence of the BCOR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72DB3586-2A55-58D9-E053-F662850A1277","latestVersionIndicator":"Yes","beginDate":"2018-08-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-08-07","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCE7A6-083C-38A0-E053-731AD00A4F58","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"BRAF Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5540283","version":"1","preferredName":"BRAF Gene Mutation","longName":"5540283","preferredDefinition":"A change in the nucleotide sequence of the BRAF gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF Gene Mutation","conceptCode":"C40430","definition":"A change in the nucleotide sequence of the BRAF gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FA1F895-F191-05B5-E053-F662850AA504","latestVersionIndicator":"Yes","beginDate":"2016-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-24","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCE7A6-083D-38A0-E053-731AD00A4F58","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"BRCA2 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"4408782","version":"1","preferredName":"BRCA2 Gene Mutation","longName":"4408782","preferredDefinition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA2 Gene Mutation","conceptCode":"C19636","definition":"A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF444164-ECAE-3A78-E040-BB89AD433300","latestVersionIndicator":"Yes","beginDate":"2014-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-28","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBCE7A6-083E-38A0-E053-731AD00A4F58","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"CCND2 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"6650937","version":"1","preferredName":"CCND2 Gene Mutation","longName":"6650937","preferredDefinition":"A change in the nucleotide sequence of the CCND2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CCND2 Gene Mutation","conceptCode":"C157379","definition":"A change in the nucleotide sequence of the CCND2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82569D70-D3AA-0D10-E053-F662850A625D","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-02-20","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD1CB7-6199-4267-E053-731AD00A291B","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"CDKN2A Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509117","version":"1","preferredName":"CDKN2A Gene Mutation","longName":"5509117","preferredDefinition":"A change in the nucleotide sequence of the CDKN2A gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A Gene Mutation","conceptCode":"C128817","definition":"A change in the nucleotide sequence of the CDKN2A gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E98A363-8D18-7B69-E053-F662850AC04B","latestVersionIndicator":"Yes","beginDate":"2016-10-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-11","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD2B2B-4FBE-44EA-E053-731AD00A23C2","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"KRAS Mutation","valueDescription":null,"ValueMeaning":{"publicId":"4514746","version":"1","preferredName":"KRAS Gene Mutation","longName":"4514746","preferredDefinition":"A change in the nucleotide sequence of the KRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KRAS Gene Mutation","conceptCode":"C41361","definition":"A change in the nucleotide sequence of the KRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"04DA251B-7CD7-0ACF-E050-BB89AD43658E","latestVersionIndicator":"Yes","beginDate":"2014-10-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-07","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD38BA-9F6A-4690-E053-731AD00AEE92","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"MYOD1 Mutation","valueDescription":null,"ValueMeaning":{"publicId":"13571182","version":"1","preferredName":"MYOD1 Gene Mutation","longName":"13571182v1.00","preferredDefinition":"A change in the nucleotide sequence of the MYOD1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYOD1 Gene Mutation","conceptCode":"C178250","definition":"A change in the nucleotide sequence of the MYOD1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBD4AA4-BD12-4903-E053-731AD00AA896","latestVersionIndicator":"Yes","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD4AA4-BD13-4903-E053-731AD00AA896","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"NF1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"4535602","version":"1","preferredName":"NF1 Gene Mutation","longName":"4535602","preferredDefinition":"A change in the nucleotide sequence of the NF1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NF1 Gene Mutation","conceptCode":"C118388","definition":"A change in the nucleotide sequence of the NF1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05670046-32B0-BC37-E050-BB89AD430FA7","latestVersionIndicator":"Yes","beginDate":"2014-10-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD5983-193B-4B16-E053-731AD00A9AA3","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"BRAF V600E","valueDescription":null,"ValueMeaning":{"publicId":"3536308","version":"1","preferredName":"BRAF NP_004324.2:p.V600E","longName":"3536308","preferredDefinition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.V600E","conceptCode":"C98342","definition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5D686D5-F5DC-76D9-E040-BB89AD433B31","latestVersionIndicator":"Yes","beginDate":"2012-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBD6CEA-E8EA-4D1C-E053-731AD00A0C03","beginDate":"2023-05-15","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-05-15","modifiedBy":"FINCHAMB","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"PDGFRA Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5576780","version":"1","preferredName":"PDGFRA Gene Mutation","longName":"5576780","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) gene on chromosome 4q12.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PDGFRA Gene Mutation","conceptCode":"C39718","definition":"A molecular genetic abnormality indicating the presence of a mutation in the PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) gene on chromosome 4q12.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"414AEB95-428F-54B0-E053-F662850A5B02","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-11-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC8BD609-DEE8-35C0-E053-731AD00A075B","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","deletedIndicator":"No"},{"value":"PIK3CA Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5495678","version":"1","preferredName":"PIK3CA Gene Mutation","longName":"5495678","preferredDefinition":"A molecular genetic abnormality indicating the presence of a mutation in the PI3KCA (phosphatidyl inositol 3-kinase) gene on chromosome 3q26.32.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PIK3CA Gene Mutation","conceptCode":"C96271","definition":"A change in the nucleotide sequence of the PIK3CA gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DBF4783-D24D-3AF0-E053-F662850A5B09","latestVersionIndicator":"Yes","beginDate":"2016-09-30","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-09-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC8BD609-DEE9-35C0-E053-731AD00A075B","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","deletedIndicator":"No"},{"value":"t(11;22), NOS","valueDescription":null,"ValueMeaning":{"publicId":"13695533","version":"1","preferredName":"t(11;22), Not Otherwise Specified","longName":"13695533v1.00","preferredDefinition":"Not characterized in any other way._A cytogenetic abnormality that involves a translocation between chromosomes 11 and 22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"t(11;22)","conceptCode":"C128642","definition":"A cytogenetic abnormality that involves a translocation between chromosomes 11 and 22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC8BD609-DEE6-35C0-E053-731AD00A075B","latestVersionIndicator":"Yes","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC8BD609-DEEA-35C0-E053-731AD00A075B","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","deletedIndicator":"No"},{"value":"t(9;15)(q22;q21)","valueDescription":null,"ValueMeaning":{"publicId":"13695534","version":"1","preferredName":"t(9;15)(q22;q21)","longName":"13695534v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;15)(q22;q21)","conceptCode":"C36394","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC8BD609-DEE7-35C0-E053-731AD00A075B","latestVersionIndicator":"Yes","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC8BD609-DEEB-35C0-E053-731AD00A075B","beginDate":"2023-05-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-25","modifiedBy":"COLBERTM","dateModified":"2023-05-25","deletedIndicator":"No"},{"value":"X Chromosome Inversion","valueDescription":null,"ValueMeaning":{"publicId":"13808687","version":"1","preferredName":"Chromosome X Inversion","longName":"13808687v1.00","preferredDefinition":"A cytogenetic abnormality that refers to any inversion of genomic material on the X chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chromosome X Inversion","conceptCode":"C199586","definition":"A cytogenetic abnormality that refers to any inversion of genomic material on the X chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-3808-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3812-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"GAB1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13808688","version":"1","preferredName":"GAB1 Gene Mutation","longName":"13808688v1.00","preferredDefinition":"A change in the nucleotide sequence of the GAB1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GAB1 Gene Mutation","conceptCode":"C199587","definition":"A change in the nucleotide sequence of the GAB1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-3809-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3813-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"GLI2 Amplification","valueDescription":null,"ValueMeaning":{"publicId":"13808689","version":"1","preferredName":"GLI2 Gene Amplification","longName":"13808689v1.00","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the GLI2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GLI2 Gene Amplification","conceptCode":"C199588","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the GLI2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380A-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3814-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"IGF1R mutation","valueDescription":null,"ValueMeaning":{"publicId":"13808690","version":"1","preferredName":"IGF1R Gene Mutation","longName":"13808690v1.00","preferredDefinition":"A change in the nucleotide sequence of the IGF1R gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IGF1R Gene Mutation","conceptCode":"C199589","definition":"A change in the nucleotide sequence of the IGF1R gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380B-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3815-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"ROBO1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13808692","version":"1","preferredName":"ROBO1 Gene Mutation","longName":"13808692v1.00","preferredDefinition":"A change in the nucleotide sequence of the ROBO1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ROBO1 Gene Mutation","conceptCode":"C199591","definition":"A change in the nucleotide sequence of the ROBO1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380D-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3816-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"SOS2 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13808693","version":"1","preferredName":"SOS2 Gene Mutation","longName":"13808693v1.00","preferredDefinition":"A change in the nucleotide sequence of the SOS2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SOS2 Gene Mutation","conceptCode":"C199592","definition":"A change in the nucleotide sequence of the SOS2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380E-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3817-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(1;10)(p22-31; q24-25)","valueDescription":null,"ValueMeaning":{"publicId":"13808694","version":"1","preferredName":"t(1;10)(p22-31;q24-25)","longName":"13808694v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (within p22-31) of chromosome 1 and the long arm (within q24-25) of chromosome 10.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(1;10)(p22-31;q24-25)","conceptCode":"C199593","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (within p22-31) of chromosome 1 and the long arm (within q24-25) of chromosome 10.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380F-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3818-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(11;16)(q13; p11)","valueDescription":null,"ValueMeaning":{"publicId":"13808695","version":"1","preferredName":"t(11;16)(q13;p11)","longName":"13808695v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q13) of chromosome 11 and the short arm (p11) of chromosome 16.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;16)(q13;p11)","conceptCode":"C199594","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q13) of chromosome 11 and the short arm (p11) of chromosome 16.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-3810-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-3819-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(11;19)(q13;q13.4)","valueDescription":null,"ValueMeaning":{"publicId":"13808696","version":"1","preferredName":"t(11;19)(q13;q13.4)","longName":"13808696v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q13) of chromosome 11 and the long arm (q13.4) of chromosome 19. It may be associated with the expression of MALAT1 gene rearrangement and undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(11;19)(q13;q13.4)","conceptCode":"C199595","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q13) of chromosome 11 and the long arm (q13.4) of chromosome 19. It may be associated with the expression of MALAT1 gene rearrangement and undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-3811-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-381A-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"PKN1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13808691","version":"1","preferredName":"PKN1 Gene Mutation","longName":"13808691v1.00","preferredDefinition":"A change in the nucleotide sequence of the PKN1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PKN1 Gene Mutation","conceptCode":"C199590","definition":"A change in the nucleotide sequence of the PKN1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636453-380C-29D8-E053-731AD00A62B4","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636453-381B-29D8-E053-731AD00A62B4","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(12;22;20)(q13;q12;q11)","valueDescription":null,"ValueMeaning":{"publicId":"13808697","version":"1","preferredName":"t(12;22;20)(q13;q12;q11)","longName":"13808697v1.00","preferredDefinition":"A complex cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q13) of chromosome 12, the long arm (q12) of chromosome 22 and the long arm (q11) of chromosome 20. It is associated with the expression of EWSR1/DDIT3 fusions and myxoid liposarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(12;22;20)(q13;q12;q11)","conceptCode":"C199596","definition":"A complex cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q13) of chromosome 12, the long arm (q12) of chromosome 22 and the long arm (q11) of chromosome 20. It is associated with the expression of EWSR1/DDIT3 fusions and myxoid liposarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BA-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C3-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(2;22)(q33.3;q12)","valueDescription":null,"ValueMeaning":{"publicId":"13808698","version":"1","preferredName":"t(2;22)(q33.3;q12)","longName":"13808698v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q33.3) of chromosome 2 and the long arm (q12) of chromosome 22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(2;22)(q33.3;q12)","conceptCode":"C199598","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q33.3) of chromosome 2 and the long arm (q12) of chromosome 22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BB-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C4-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(5;18)(q35;q11)","valueDescription":null,"ValueMeaning":{"publicId":"13808699","version":"1","preferredName":"t(5;18)(q35;q11)","longName":"13808699v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q35) of chromosome 5 and the long arm (q11) of chromosome 18.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(5;18)(q35;q11)","conceptCode":"C199600","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (q35) of chromosome 5 and the long arm (q11) of chromosome 18.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BC-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C5-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(9;17)(q22;q11.2)","valueDescription":null,"ValueMeaning":{"publicId":"13808701","version":"1","preferredName":"t(9;17)(q22;q11.2)","longName":"13808701v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q22) of chromosome 9 and the long arm (q11.2) of chromosome 17. It may be associated with the expression of TAF15/NR4A3 fusions and extraskeletal myxoid chondrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;17)(q22;q11.2)","conceptCode":"C199602","definition":"A cytogenetic abnormality that refers to a chromosomal translocation involving the long arm (q22) of chromosome 9 and the long arm (q11.2) of chromosome 17. It may be associated with the expression of TAF15/NR4A3 fusions and extraskeletal myxoid chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BE-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C6-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(9;22)(q22-23;q11-12)","valueDescription":null,"ValueMeaning":{"publicId":"13808702","version":"1","preferredName":"t(9;22)(q22-23;q11-12)","longName":"13808702v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (within q22-23) of chromosome 9 and the long arm (within q11-12) of chromosome 22.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(9;22)(q22-23;q11-12)","conceptCode":"C199603","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the long arm (within q22-23) of chromosome 9 and the long arm (within q11-12) of chromosome 22.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BF-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C7-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(X;18)(p11.21;q11)","valueDescription":null,"ValueMeaning":{"publicId":"13808703","version":"1","preferredName":"t(X;18)(p11.21;q11)","longName":"13808703v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.21) of the X chromosome and the long arm (q11) of chromosome 18. It is associated with the expression of SS18/SSX2 fusions and the development of synovial sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;18)(p11.21;q11)","conceptCode":"C199604","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.21) of the X chromosome and the long arm (q11) of chromosome 18. It is associated with the expression of SS18/SSX2 fusions and the development of synovial sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19C0-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C8-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(X;18)(p11.23;q11)","valueDescription":null,"ValueMeaning":{"publicId":"13808704","version":"1","preferredName":"t(X;18)(p11.23;q11)","longName":"13808704v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.23) of the X chromosome and the long arm (q11) of chromosome 18. It is associated with the expression of SS18/SSX1 fusions and the development of synovial sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;18)(p11.23;q11)","conceptCode":"C199605","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.23) of the X chromosome and the long arm (q11) of chromosome 18. It is associated with the expression of SS18/SSX1 fusions and the development of synovial sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19C1-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19C9-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(X;20)(p11.2;q13.3)","valueDescription":null,"ValueMeaning":{"publicId":"13808705","version":"1","preferredName":"t(X;20)(p11.2;q13.3)","longName":"13808705v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.2) of the X chromosome and the long arm (q13.3) of chromosome 20.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(X;20)(p11.2;q13.3)","conceptCode":"C199606","definition":"A cytogenetic abnormality that refers to a chromosomal translocation that involves the short arm (p11.2) of the X chromosome and the long arm (q13.3) of chromosome 20.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19C2-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19CA-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"t(8;8)(q21;q13)","valueDescription":null,"ValueMeaning":{"publicId":"13808700","version":"1","preferredName":"t(8;8)(q13;q21)","longName":"13808700v1.00","preferredDefinition":"A cytogenetic abnormality that refers to a chromosomal translocation involving 2 break points within the long arm (q13 and q21) of chromosome 8. It may be associated with the expression of CA3/MYBL1 fusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"t(8;8)(q13;q21)","conceptCode":"C199601","definition":"A cytogenetic abnormality that refers to a chromosomal translocation involving 2 break points within the long arm (q13 and q21) of chromosome 8. It may be associated with the expression of CA3/MYBL1 fusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD636838-19BD-2ADB-E053-731AD00A75F6","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD636838-19CB-2ADB-E053-731AD00A75F6","beginDate":"2023-06-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-05","modifiedBy":"SOKKERL","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"SMARCB1 deleted/mutated","valueDescription":null,"ValueMeaning":{"publicId":"13808959","version":"1","preferredName":"SMARCB1 Deletion Or Mutation","longName":"13808959v1.00","preferredDefinition":"Any deletion mutation that occurs within a gene, including the 5' and 3' untranslated regions of the gene._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._This gene plays a role in chromatin remodeling and regulation of transcription.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Deletion","conceptCode":"C16606","definition":"A deletion that results in the loss of a DNA segment encompassing an entire gene sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"SMARCB1 Gene","conceptCode":"C18394","definition":"This gene plays a role in chromatin remodeling and regulation of transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD674586-102F-578E-E053-731AD00ABFF9","latestVersionIndicator":"Yes","beginDate":"2023-06-05","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-06-05","modifiedBy":"COLBERTM","dateModified":"2023-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD674586-1030-578E-E053-731AD00ABFF9","beginDate":"2023-06-05","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-06-05","modifiedBy":"COLBERTM","dateModified":"2023-06-05","deletedIndicator":"No"},{"value":"ROS1 rearranged","valueDescription":null,"ValueMeaning":{"publicId":"5782128","version":"1","preferredName":"ROS1 Gene Rearrangement","longName":"5782128","preferredDefinition":"A molecular abnormality indicating rearrangement of the ROS1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ROS1 Gene Rearrangement","conceptCode":"C130236","definition":"A molecular abnormality indicating rearrangement of the ROS1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E132C83-F3D0-570C-E053-F662850A027B","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-04-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E006-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"FBXW7 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5629233","version":"1","preferredName":"FBXW7 Gene Mutation","longName":"5629233","preferredDefinition":"A change in the nucleotide sequence of the FBXW7 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FBXW7 Gene Mutation","conceptCode":"C131484","definition":"A change in the nucleotide sequence of the FBXW7 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4660FED2-2754-2E94-E053-F662850A4700","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E007-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"MTOR mutation","valueDescription":null,"ValueMeaning":{"publicId":"5782225","version":"1","preferredName":"MTOR Gene Mutation","longName":"5782225","preferredDefinition":"A change in the nucleotide sequence of the MTOR gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MTOR Gene Mutation","conceptCode":"C133686","definition":"A change in the nucleotide sequence of the MTOR gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E166D13-5AAB-52E4-E053-F662850AD88B","latestVersionIndicator":"Yes","beginDate":"2017-04-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-04-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E008-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"DICER1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"5916756","version":"1","preferredName":"DICER1 Gene Mutation.","longName":"5916756","preferredDefinition":"A change in the nucleotide sequence of the DICER1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DICER1 Gene Mutation","conceptCode":"C137691","definition":"A change in the nucleotide sequence of the DICER1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55A31A42-1FFF-479A-E053-F662850A8F8B","latestVersionIndicator":"Yes","beginDate":"2017-07-31","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-07-31","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E009-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"SMARCA4 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6047204","version":"1","preferredName":"SMARCA4 Gene Mutation","longName":"6047204","preferredDefinition":"A change in the nucleotide sequence of the SMARCA4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SMARCA4 Gene Mutation","conceptCode":"C142126","definition":"A change in the nucleotide sequence of the SMARCA4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61E72180-7B6F-4F70-E053-F662850A045B","latestVersionIndicator":"Yes","beginDate":"2018-01-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-01-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00A-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"CCND1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6153946","version":"1","preferredName":"CCND1 Gene Mutation","longName":"6153946","preferredDefinition":"A change in the nucleotide sequence of the CCND1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CCND1 Gene Mutation","conceptCode":"C142846","definition":"A change in the nucleotide sequence of the CCND1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"685ABAE7-F759-19EC-E053-F662850A2176","latestVersionIndicator":"Yes","beginDate":"2018-03-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-03-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00B-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"p.F1174L","valueDescription":null,"ValueMeaning":{"publicId":"6060206","version":"1","preferredName":"ALK NP_004295.2:p.F1174L ","longName":"6060206","preferredDefinition":"A change in the amino acid residue at position 1174 in the ALK tyrosine kinase receptor protein where phenylalanine has been replaced by leucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK NP_004295.2:p.F1174L","conceptCode":"C146863","definition":"A change in the amino acid residue at position 1174 in the ALK tyrosine kinase receptor protein where phenylalanine has been replaced by leucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2427-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00C-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"CDK4 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6334954","version":"1","preferredName":"CDK4 Gene Mutation","longName":"6334954","preferredDefinition":"A change in the nucleotide sequence of the CDK4 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDK4 Gene Mutation","conceptCode":"C150474","definition":"A change in the nucleotide sequence of the CDK4 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E87AABC-2DAF-199C-E053-F662850A603C","latestVersionIndicator":"Yes","beginDate":"2018-06-13","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-06-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00D-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"ETV6 rearranged","valueDescription":null,"ValueMeaning":{"publicId":"6536240","version":"1","preferredName":"ETV6 Gene Rearrangement","longName":"6536240","preferredDefinition":"A molecular abnormality indicating rearrangement of the ETV6 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ETV6 Gene Rearrangement","conceptCode":"C155992","definition":"A molecular abnormality indicating rearrangement of the ETV6 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78F88E5D-8249-5B95-E053-F662850ABBB1","latestVersionIndicator":"Yes","beginDate":"2018-10-24","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-10-24","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00E-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"ARID1A mutation","valueDescription":null,"ValueMeaning":{"publicId":"6651849","version":"1","preferredName":"ARID1A Gene Mutation","longName":"6651849","preferredDefinition":"A change in the nucleotide sequence of the ARID1A gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ARID1A Gene Mutation","conceptCode":"C157462","definition":"A change in the nucleotide sequence of the ARID1A gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8269E4A5-9407-15A9-E053-F662850A07AC","latestVersionIndicator":"Yes","beginDate":"2019-02-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-02-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD757CA6-E00F-5286-E053-731AD00A335B","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"NTRK Rearranged","valueDescription":null,"ValueMeaning":{"publicId":"7239843","version":"1","preferredName":"NTRK Gene Rearrangement","longName":"7239843","preferredDefinition":"A molecular abnormality indicating cytogenetic rearrangement involving an NTRK family gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NTRK Gene Rearrangement","conceptCode":"C171043","definition":"A molecular abnormality indicating cytogenetic rearrangement involving an NTRK family gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2A6B614-62AC-6B78-E053-F662850A0035","latestVersionIndicator":"Yes","beginDate":"2020-04-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2020-04-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C096-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"TLS/FEV","valueDescription":null,"ValueMeaning":{"publicId":"13343405","version":"1","preferredName":"FUS/FEV Fusion Gene","longName":"13343405v1.00","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(2;16)(q35;p11) which fuses exon 10 of the FUS gene with exon 2 of the FEV gene. This rearrangement is associated with Ewing sarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FUS/FEV Fusion Gene","conceptCode":"C174466","definition":"A fusion gene that results from a chromosomal translocation t(2;16)(q35;p11) which fuses exon 10 of the FUS gene with exon 2 of the FEV gene. This rearrangement is associated with Ewing sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9162EF8-0445-279D-E053-731AD00AC4B8","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-11","modifiedBy":"SOKKERL","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C097-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"ALK p.R1275L mutation","valueDescription":null,"ValueMeaning":{"publicId":"13809181","version":"1","preferredName":"ALK NP_004295.2:p.R1275L","longName":"13809181v1.00","preferredDefinition":"A change in the amino acid residue at position 1275 in the ALK tyrosine kinase receptor protein where arginine has been replaced by leucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK NP_004295.2:p.R1275L","conceptCode":"C175957","definition":"A change in the amino acid residue at position 1275 in the ALK tyrosine kinase receptor protein where arginine has been replaced by leucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD758658-C092-53BD-E053-731AD00AF4DA","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C098-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"47XXX","valueDescription":null,"ValueMeaning":{"publicId":"13809183","version":"1","preferredName":"47,XXX Karyotype","longName":"13809183v1.00","preferredDefinition":"An abnormal sex chromosome karyotype where the individual has three copies of the X chromosome. The normal autosomal karyotype is present. This karyotype is associated with triple X syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"47,XXX Karyotype","conceptCode":"C176785","definition":"An abnormal sex chromosome karyotype where the individual has three copies of the X chromosome. The normal autosomal karyotype is present. This karyotype is associated with triple X syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD758658-C094-53BD-E053-731AD00AF4DA","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C099-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"SOS1 mutation","valueDescription":null,"ValueMeaning":{"publicId":"7748787","version":"1","preferredName":"SOS1 Gene Mutation","longName":"7748787","preferredDefinition":"A change in the nucleotide sequence of the SOS1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SOS1 Gene Mutation","conceptCode":"C180788","definition":"A change in the nucleotide sequence of the SOS1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C8086820-82E8-7BE5-E053-4EBD850AFEE9","latestVersionIndicator":"Yes","beginDate":"2021-07-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-07-26","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09A-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"MYCN mutation","valueDescription":null,"ValueMeaning":{"publicId":"13809184","version":"1","preferredName":"MYCN Gene Mutation","longName":"13809184v1.00","preferredDefinition":"A change in the nucleotide sequence of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYCN Gene Mutation","conceptCode":"C188674","definition":"A change in the nucleotide sequence of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD758658-C095-53BD-E053-731AD00AF4DA","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09B-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"17q Gain","valueDescription":null,"ValueMeaning":{"publicId":"6052747","version":"1","preferredName":"Gain of Chromosome 17q","longName":"6052747v1.00","preferredDefinition":"A cytogenetic abnormality that refers to the duplication of all or part of the long arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gain of Chromosome 17q","conceptCode":"C36484","definition":"A cytogenetic abnormality that refers to the duplication of all or part of the long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630EC3B2-8D3D-7E5F-E053-F662850AC85A","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-01-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09C-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"Loss of Chromosome 1p (Deletion)","valueDescription":null,"ValueMeaning":{"publicId":"3227260","version":"1","preferredName":"Loss of Chromosome 1p","longName":"3227260","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of the chromosomal arm 1p. It has been described in gliomas, meningiomas, neuroblastomas, hepatocellular carcinomas, breast carcinomas, acinar prostate adenocarcinomas, pancreatic carcinomas, and adrenal gland adenomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 1p","conceptCode":"C36501","definition":"A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 1 (1p). It has been described in gliomas, meningiomas, neuroblastomas, hepatocellular carcinomas, breast carcinomas, acinar prostate adenocarcinomas, pancreatic carcinomas, and adrenal gland adenomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0C3F27F-95EA-358A-E040-BB89AD43602C","latestVersionIndicator":"Yes","beginDate":"2011-04-12","endDate":null,"createdBy":"WHITES","dateCreated":"2011-04-12","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09D-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"MYCN Amplification","valueDescription":null,"ValueMeaning":{"publicId":"5609858","version":"1","preferredName":"NMYC Gene Amplification","longName":"5609858","preferredDefinition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NMYC Gene Amplification","conceptCode":"C36673","definition":"A molecular genetic abnormality indicating the presence of multiple copies of the MYCN gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"442EACBA-844B-5C0F-E053-F662850A9775","latestVersionIndicator":"Yes","beginDate":"2016-12-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-12-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09E-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"Loss of Chromosome 11q (Deletion)","valueDescription":null,"ValueMeaning":{"publicId":"5629221","version":"1","preferredName":"Loss of Chromosome 11q","longName":"5629221","preferredDefinition":"A cytogenetic abnormality that refers to the allelic loss of all or part of the long arm of chromosome 11.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss of Chromosome 11q","conceptCode":"C37312","definition":"A cytogenetic abnormality that refers to the loss of all or part of the long arm of chromosome 11 (11q).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4660FED2-2571-2E94-E053-F662850A4700","latestVersionIndicator":"Yes","beginDate":"2017-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C09F-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"FOXO1 rearranged","valueDescription":null,"ValueMeaning":{"publicId":"13809182","version":"1","preferredName":"FOXO1 Gene Rearrangement","longName":"13809182v1.00","preferredDefinition":"A molecular abnormality indicating rearrangement of the FOXO1 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FOXO1 Gene Rearrangement","conceptCode":"C175960","definition":"A molecular abnormality indicating rearrangement of the FOXO1 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD758658-C093-53BD-E053-731AD00AF4DA","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD758658-C0A0-53BD-E053-731AD00AF4DA","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"MDM2 mutation","valueDescription":null,"ValueMeaning":{"publicId":"13809185","version":"1","preferredName":"MDM2 Gene Mutation","longName":"13809185v1.00","preferredDefinition":"A change in the nucleotide sequence of the MDM2 gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDM2 Gene Mutation","conceptCode":"C39717","definition":"A change in the nucleotide sequence of the MDM2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD7589EF-005A-543F-E053-731AD00AA95C","latestVersionIndicator":"Yes","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-005B-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"NRAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"5509092","version":"1","preferredName":"NRAS Gene Mutation","longName":"5509092","preferredDefinition":"A change in the structure of the NRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NRAS Gene Mutation","conceptCode":"C41381","definition":"A change in the structure of the NRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E984DAC-540A-3B8C-E053-F662850ABB84","latestVersionIndicator":"Yes","beginDate":"2016-10-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-10-11","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-005C-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"HRAS mutation","valueDescription":null,"ValueMeaning":{"publicId":"5654907","version":"1","preferredName":"HRAS Gene Mutation","longName":"5654907","preferredDefinition":"A change in the nucleotide sequence of the HRAS gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HRAS Gene Mutation","conceptCode":"C45934","definition":"A change in the nucleotide sequence of the HRAS gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"47E1D321-50DA-5A79-E053-F662850A5552","latestVersionIndicator":"Yes","beginDate":"2017-02-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2017-02-06","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-005D-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"ALK Mutation","valueDescription":null,"ValueMeaning":{"publicId":"5574456","version":"1","preferredName":"ALK Gene Mutation","longName":"5574456","preferredDefinition":"A molecular genetic abnormality that refers to the presence of a mutation in the ALK gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Gene Mutation","conceptCode":"C81945","definition":"A molecular genetic abnormality that refers to the presence of a mutation in the ALK gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4146800A-E668-0853-E053-F662850A5C7F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"COLBERTM","dateCreated":"2016-11-14","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-005E-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"FGFR4 mutation","valueDescription":null,"ValueMeaning":{"publicId":"6052772","version":"1","preferredName":"FGFR4 Gene Mutation","longName":"6052772","preferredDefinition":"Mutation of the fibroblast growth factor receptor 4 gene which is located on the long arm of chromosome 5. It has been described in patients with childhood rhabdomyosarcoma. Overexpression of this gene in these patients is associated with advanced stage disease and poor survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FGFR4 Gene Mutation","conceptCode":"C84092","definition":"Mutation of the fibroblast growth factor receptor 4 gene which is located on the long arm of chromosome 5. It has been described in patients with childhood rhabdomyosarcoma. Overexpression of this gene in these patients is associated with advanced stage disease and poor survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630F1C50-DEDF-7EE9-E053-F662850A5364","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-005F-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"},{"value":"AKT mutation","valueDescription":null,"ValueMeaning":{"publicId":"6052765","version":"1","preferredName":"AKT Family Gene Mutation","longName":"6052765","preferredDefinition":"A molecular genetic abnormality indicating the presence of mutations in the AKT family of genes.  This family includes the AKT1, AKT2, and AKT3 genes that are located on chromosomes 14, 19, and 1, respectively.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AKT Family Gene Mutation","conceptCode":"C96865","definition":"A molecular genetic abnormality indicating the presence of mutations in the AKT family of genes.  This family includes the AKT1, AKT2, and AKT3 genes that are located on chromosomes 14, 19, and 1, respectively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630F1C50-DE3F-7EE9-E053-F662850A5364","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2018-01-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7589EF-0060-543F-E053-731AD00AA95C","beginDate":"2023-06-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-06-06","modifiedBy":"SOKKERL","dateModified":"2023-06-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7507227","version":"1","preferredName":"Gene Mutation Name","preferredDefinition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.:The words or language units by which a thing is known.","longName":"C18093:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Mutation","conceptCode":"C18093","definition":"The result of any gain, loss or alteration of the sequences comprising a gene, including all sequences transcribed into RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4648A18-3D3B-5E66-E053-4EBD850A0245","latestVersionIndicator":"Yes","beginDate":"2020-11-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-11-18","modifiedBy":"ONEDATA","dateModified":"2020-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F9128A36-9735-73BF-E053-731AD00A766D","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-14","changeDescription":null,"administrativeNotes":"2023.8.14 Updated def for 'No Value Exists'. ak 4/11/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173196","version":"1","longName":"Genetic Analysis","context":"Pediatric Cancer"},{"publicId":"12173177","version":"1","longName":"Testing","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"COMMON_NAME","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Common Name","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F952F235-DCBF-5680-E053-731AD00AEDAF","latestVersionIndicator":"Yes","beginDate":"2023-04-14","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-14","modifiedBy":"SOKKERL","dateModified":"2023-05-09","changeDescription":null,"administrativeNotes":"4/14/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}